| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR51T1 MRC1 IL12RB2 VLDLR FLT1 FLT3 FLT4 CRLF1 PDGFRA GPR32P1 NTRK1 GPR182 GRIK1 GRIK5 ACVRL1 PTH2R CHRNA7 SORCS1 IFNAR1 FZD1 CSF1R PKD1 TAS1R1 LRP5 SORCS3 CD72 CCR7 IL1R1 CHRFAM7A ALK GPR151 EPHA3 GABRA2 GP1BA AGTRAP | 1.16e-09 | 1353 | 165 | 35 | GO:0004888 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCA2 GJB4 CYB561D2 MPEG1 SLC13A3 GRIK1 GRIK5 SLC9C2 ABCA8 CHRNA7 SLC6A8 SLC7A1 SLC7A3 CLCN3 KCNQ5 ABCB9 SLC14A1 SLC22A16 ABCA6 SLC17A9 PRF1 PKD1 KCNQ1 KCNQ2 LRP5 PACC1 GJB7 ATP2A3 CHRFAM7A TAP2 ATP6V0A2 GABRA2 | 2.20e-09 | 1180 | 165 | 32 | GO:0022857 |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | FLT1 FLT3 FLT4 PDGFRA MATK NTRK1 JAK1 CSF1R CSK PRKCD ALK EPHA3 | 2.96e-09 | 145 | 165 | 12 | GO:0004713 |
| GeneOntologyMolecularFunction | transporter activity | ABCA2 GJB4 CETP CYB561D2 MPEG1 SLC13A3 GRIK1 GRIK5 SLC9C2 ABCA8 CHRNA7 SLC6A8 SLC7A1 SLC7A3 CLCN3 KCNQ5 ABCB9 SLC14A1 SLC22A16 ABCA6 SLC17A9 PRF1 PKD1 KCNQ1 KCNQ2 LRP5 PACC1 GJB7 ATP2A3 CHRFAM7A TAP2 ATP6V0A2 GABRA2 | 4.94e-09 | 1289 | 165 | 33 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 3.47e-08 | 85 | 165 | 9 | GO:0019199 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 6.20e-08 | 65 | 165 | 8 | GO:0004714 | |
| GeneOntologyMolecularFunction | protein kinase activity | FLT1 FLT3 FLT4 PDGFRA MATK NTRK1 GRK4 ACVRL1 JAK1 STK32A CSF1R CSK GUCY2F MAP3K9 PRKCD PRKCG MAP3K21 ALK RPS6KL1 EPHA3 | 1.26e-07 | 600 | 165 | 20 | GO:0004672 |
| GeneOntologyMolecularFunction | vascular endothelial growth factor receptor activity | 1.54e-07 | 7 | 165 | 4 | GO:0005021 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | FLT1 FLT3 FLT4 PDGFRA MATK NTRK1 GRK4 ACVRL1 JAK1 STK32A CSF1R CSK GUCY2F MAP3K9 AGK PRKCD PRKCG MAP3K21 ALK RPS6KL1 EPHA3 | 4.21e-07 | 709 | 165 | 21 | GO:0016773 |
| GeneOntologyMolecularFunction | kinase activity | FLT1 FLT3 FLT4 PDGFRA MATK NTRK1 GRK4 ACVRL1 JAK1 STK32A CSF1R CSK GUCY2F MAP3K9 AGK PRKCD PRKCG MAP3K21 ALK RPS6KL1 EPHA3 | 1.40e-06 | 764 | 165 | 21 | GO:0016301 |
| GeneOntologyMolecularFunction | peptide receptor activity | GPR32P1 GPR182 PTH2R SORCS1 GUCY2F SORCS3 GPR151 GP1BA AGTRAP | 2.51e-06 | 140 | 165 | 9 | GO:0001653 |
| GeneOntologyMolecularFunction | growth factor binding | 6.10e-06 | 156 | 165 | 9 | GO:0019838 | |
| GeneOntologyMolecularFunction | channel activity | GJB4 MPEG1 GRIK1 GRIK5 CHRNA7 CLCN3 KCNQ5 SLC14A1 PRF1 PKD1 KCNQ1 KCNQ2 PACC1 GJB7 CHRFAM7A GABRA2 | 7.69e-06 | 525 | 165 | 16 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GJB4 MPEG1 GRIK1 GRIK5 CHRNA7 CLCN3 KCNQ5 SLC14A1 PRF1 PKD1 KCNQ1 KCNQ2 PACC1 GJB7 CHRFAM7A GABRA2 | 7.87e-06 | 526 | 165 | 16 | GO:0022803 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | PIGN FLT1 FLT3 FLT4 PDGFRA MATK NTRK1 GRK4 ACVRL1 JAK1 STK32A CSF1R CSK GUCY2F MAP3K9 AGK PRKCD PRKCG MAP3K21 ALK RPS6KL1 EPHA3 | 9.95e-06 | 938 | 165 | 22 | GO:0016772 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.50e-05 | 133 | 165 | 8 | GO:0008528 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 3.40e-05 | 109 | 165 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 5.15e-05 | 49 | 165 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | retinol isomerase activity | 6.79e-05 | 2 | 165 | 2 | GO:0050251 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.07e-04 | 57 | 165 | 5 | GO:1904315 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.19e-04 | 178 | 165 | 8 | GO:0015399 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.37e-04 | 60 | 165 | 5 | GO:0099529 | |
| GeneOntologyMolecularFunction | cytokine receptor activity | 1.54e-04 | 97 | 165 | 6 | GO:0004896 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCA2 CYB561D2 SLC13A3 SLC9C2 ABCA8 SLC6A8 CLCN3 ABCB9 ABCA6 SLC17A9 ATP2A3 TAP2 ATP6V0A2 | 1.73e-04 | 477 | 165 | 13 | GO:0022804 |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 2.01e-04 | 65 | 165 | 5 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 2.01e-04 | 65 | 165 | 5 | GO:0022824 | |
| GeneOntologyMolecularFunction | monoamine oxidase activity | 2.03e-04 | 3 | 165 | 2 | GO:0097621 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 2.38e-04 | 105 | 165 | 6 | GO:0015171 | |
| GeneOntologyMolecularFunction | wide pore channel activity | 2.40e-04 | 37 | 165 | 4 | GO:0022829 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 2.64e-04 | 310 | 165 | 10 | GO:0030246 | |
| GeneOntologyMolecularFunction | cytokine binding | 3.34e-04 | 157 | 165 | 7 | GO:0019955 | |
| GeneOntologyMolecularFunction | carboxylic ester hydrolase activity | 3.34e-04 | 157 | 165 | 7 | GO:0052689 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 3.46e-04 | 17 | 165 | 3 | GO:0042813 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 3.92e-04 | 75 | 165 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | ABC-type peptide transporter activity | 4.03e-04 | 4 | 165 | 2 | GO:0015440 | |
| GeneOntologyMolecularFunction | aliphatic amine oxidase activity | 4.03e-04 | 4 | 165 | 2 | GO:0052595 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 4.43e-04 | 77 | 165 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | immune receptor activity | 4.51e-04 | 165 | 165 | 7 | GO:0140375 | |
| GeneOntologyMolecularFunction | gated channel activity | GRIK1 GRIK5 CHRNA7 CLCN3 KCNQ5 KCNQ1 KCNQ2 PACC1 CHRFAM7A GABRA2 | 4.75e-04 | 334 | 165 | 10 | GO:0022836 |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 5.60e-04 | 46 | 165 | 4 | GO:0004715 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC13A3 GRIK1 GRIK5 SLC9C2 CHRNA7 SLC6A8 CLCN3 KCNQ5 SLC14A1 PKD1 KCNQ1 KCNQ2 PACC1 ATP2A3 ATP6V0A2 GABRA2 | 5.61e-04 | 758 | 165 | 16 | GO:0015318 |
| GeneOntologyMolecularFunction | L-ornithine transmembrane transporter activity | 6.68e-04 | 5 | 165 | 2 | GO:0000064 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC13A3 GRIK1 GRIK5 SLC9C2 CHRNA7 SLC6A8 CLCN3 KCNQ5 PKD1 KCNQ1 KCNQ2 PACC1 ATP2A3 CHRFAM7A ATP6V0A2 GABRA2 | 9.06e-04 | 793 | 165 | 16 | GO:0015075 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 9.87e-04 | 24 | 165 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 9.96e-04 | 6 | 165 | 2 | GO:0015277 | |
| GeneOntologyMolecularFunction | GPI-linked ephrin receptor activity | 1.39e-03 | 7 | 165 | 2 | GO:0005004 | |
| GeneOntologyMolecularFunction | D-mannose binding | 1.40e-03 | 27 | 165 | 3 | GO:0005537 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.45e-03 | 100 | 165 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GRIK1 GRIK5 CHRNA7 CLCN3 KCNQ5 PKD1 KCNQ1 KCNQ2 PACC1 CHRFAM7A GABRA2 | 1.55e-03 | 459 | 165 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC13A3 GRIK1 GRIK5 SLC9C2 CHRNA7 SLC6A8 KCNQ5 PKD1 KCNQ1 KCNQ2 ATP2A3 | 1.72e-03 | 465 | 165 | 11 | GO:0046873 |
| GeneOntologyMolecularFunction | fucose binding | 1.84e-03 | 8 | 165 | 2 | GO:0042806 | |
| GeneOntologyMolecularFunction | L-lysine transmembrane transporter activity | 2.35e-03 | 9 | 165 | 2 | GO:0015189 | |
| GeneOntologyMolecularFunction | peptide transmembrane transporter activity | 2.35e-03 | 9 | 165 | 2 | GO:1904680 | |
| GeneOntologyMolecularFunction | primary methylamine oxidase activity | 2.35e-03 | 9 | 165 | 2 | GO:0008131 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 2.52e-03 | 33 | 165 | 3 | GO:0072349 | |
| GeneOntologyMolecularFunction | phospholipase activity | 2.58e-03 | 114 | 165 | 5 | GO:0004620 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 2.68e-03 | 167 | 165 | 6 | GO:0015079 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 2.84e-03 | 71 | 165 | 4 | GO:0015179 | |
| GeneOntologyMolecularFunction | pore-forming activity | 2.92e-03 | 10 | 165 | 2 | GO:0140911 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | FLT4 PDGFRA NTRK1 MORC2 CHRNA7 CARD8 FZD1 FAP CSF1R ABCB9 KLRF2 MAP3K9 MAP3K21 CHRFAM7A TAP2 | 3.17e-03 | 815 | 165 | 15 | GO:0042803 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC13A3 GRIK1 GRIK5 SLC9C2 CHRNA7 SLC6A8 KCNQ5 PKD1 KCNQ1 KCNQ2 ATP2A3 CHRFAM7A ATP6V0A2 | 3.54e-03 | 664 | 165 | 13 | GO:0008324 |
| GeneOntologyMolecularFunction | potassium channel activity | 4.24e-03 | 128 | 165 | 5 | GO:0005267 | |
| GeneOntologyMolecularFunction | JUN kinase kinase kinase activity | 4.24e-03 | 12 | 165 | 2 | GO:0004706 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine phosphorylation | IL12RB2 FLT1 FLT3 FLT4 CRLF1 PDGFRA NTRK1 ZZEF1 IFNAR1 JAK1 CSF1R PRKCD ALK EPHA3 | 3.74e-07 | 327 | 164 | 14 | GO:0018108 |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine modification | IL12RB2 FLT1 FLT3 FLT4 CRLF1 PDGFRA NTRK1 ZZEF1 IFNAR1 JAK1 CSF1R PRKCD ALK EPHA3 | 4.02e-07 | 329 | 164 | 14 | GO:0018212 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | IL12RB2 FLT1 FLT3 FLT4 DPY19L3 CRLF1 QPCTL PDGFRA DPH7 NTRK1 PPP1R15A ZZEF1 ACE CHRNA7 IFNAR1 JAK1 STK32A CSF1R PKD1 PRKCD PRKCG CHRFAM7A ALK EPHA3 | 8.46e-07 | 976 | 164 | 24 | GO:0018193 |
| GeneOntologyBiologicalProcess | import into cell | MRC1 VLDLR ABCA2 GRK4 KIAA0319L APOC3 SLC9C2 LYST CHRNA7 PLA2R1 SLC7A1 SLC7A3 CLCN3 CSK DNM3 KCNQ1 KCNQ2 LRP5 PRKCD PRKCG CCR7 CLEC10A LY75 CHRFAM7A EPHA3 | 1.32e-06 | 1074 | 164 | 25 | GO:0098657 |
| GeneOntologyBiologicalProcess | endocytosis | MRC1 VLDLR ABCA2 GRK4 KIAA0319L APOC3 LYST CHRNA7 PLA2R1 CLCN3 CSK DNM3 KCNQ2 LRP5 PRKCD PRKCG CCR7 CLEC10A LY75 CHRFAM7A EPHA3 | 2.66e-06 | 827 | 164 | 21 | GO:0006897 |
| GeneOntologyBiologicalProcess | phospholipid metabolic process | PIGN ABCA2 CETP PLA2G4D LYST ABCA8 LCLAT1 SACM1L CISH PNPLA6 ABHD16B PRKCD SMPD2 ABHD16A | 5.33e-06 | 410 | 164 | 14 | GO:0006644 |
| GeneOntologyBiologicalProcess | phospholipid catabolic process | 8.09e-06 | 60 | 164 | 6 | GO:0009395 | |
| GeneOntologyBiologicalProcess | sphingomyelin metabolic process | 2.07e-05 | 21 | 164 | 4 | GO:0006684 | |
| GeneOntologyBiologicalProcess | lymph vessel morphogenesis | 3.62e-05 | 24 | 164 | 4 | GO:0036303 | |
| GeneOntologyBiologicalProcess | membrane lipid biosynthetic process | 3.77e-05 | 157 | 164 | 8 | GO:0046467 | |
| GeneOntologyBiologicalProcess | sphingolipid biosynthetic process | 4.21e-05 | 117 | 164 | 7 | GO:0030148 | |
| GeneOntologyBiologicalProcess | phenylethylamine metabolic process | 6.28e-05 | 2 | 164 | 2 | GO:0042443 | |
| GeneOntologyBiologicalProcess | positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure | 6.28e-05 | 2 | 164 | 2 | GO:0001988 | |
| GeneOntologyBiologicalProcess | behavior | VLDLR ABCA2 ZMPSTE24 GJB4 NTRK1 GRIK1 ZZEF1 ACE CHRNA7 YTHDF1 CLCN3 RAPGEF3 KCNQ1 KCNQ2 SORCS3 PRKCG CHRFAM7A ALK NPAS4 | 8.94e-05 | 891 | 164 | 19 | GO:0007610 |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 9.04e-05 | 228 | 164 | 9 | GO:0046777 | |
| GeneOntologyBiologicalProcess | lymph vessel development | 1.16e-04 | 32 | 164 | 4 | GO:0001945 | |
| GeneOntologyBiologicalProcess | regulation of synaptic plasticity | GRIK1 ZZEF1 ACE CHRNA7 YTHDF1 KCNQ2 SORCS3 PRKCG CHRFAM7A NPAS4 | 1.23e-04 | 293 | 164 | 10 | GO:0048167 |
| GeneOntologyBiologicalProcess | antigen processing and presentation | 1.25e-04 | 139 | 164 | 7 | GO:0019882 | |
| GeneOntologyBiologicalProcess | glycerolipid metabolic process | PIGN CETP APOC3 SCD5 PLA2G4D LCLAT1 SACM1L CISH PNPLA6 ABHD16B AGK ABHD16A | 1.71e-04 | 429 | 164 | 12 | GO:0046486 |
| GeneOntologyBiologicalProcess | baroreceptor response to decreased systemic arterial blood pressure | 1.88e-04 | 3 | 164 | 2 | GO:0001982 | |
| GeneOntologyBiologicalProcess | lysine transport | 1.88e-04 | 3 | 164 | 2 | GO:0015819 | |
| GeneOntologyBiologicalProcess | learning or memory | VLDLR NTRK1 ZZEF1 CHRNA7 YTHDF1 RAPGEF3 KCNQ2 SORCS3 PRKCG CHRFAM7A NPAS4 | 2.04e-04 | 373 | 164 | 11 | GO:0007611 |
| GeneOntologyBiologicalProcess | glycerophospholipid catabolic process | 2.07e-04 | 37 | 164 | 4 | GO:0046475 | |
| GeneOntologyBiologicalProcess | positive regulation of amide metabolic process | 2.07e-04 | 37 | 164 | 4 | GO:0034250 | |
| GeneOntologyBiologicalProcess | glycerolipid catabolic process | 2.38e-04 | 70 | 164 | 5 | GO:0046503 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | ACER2 ACADM APOC3 PLA2G4D PNPLA6 ABHD16B PRKCD SMPD2 CYP4F11 ALK ABHD16A | 2.50e-04 | 382 | 164 | 11 | GO:0016042 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | NTRK1 GRIK1 GRIK5 ZZEF1 ACE SYNPR CHRNA7 FBXO2 YTHDF1 KCNQ2 SORCS3 PRKCG CHRFAM7A NPAS4 GPR151 | 2.74e-04 | 663 | 164 | 15 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | NTRK1 GRIK1 GRIK5 ZZEF1 ACE SYNPR CHRNA7 FBXO2 YTHDF1 KCNQ2 SORCS3 PRKCG CHRFAM7A NPAS4 GPR151 | 2.78e-04 | 664 | 164 | 15 | GO:0099177 |
| GeneOntologyBiologicalProcess | ceramide metabolic process | 2.89e-04 | 113 | 164 | 6 | GO:0006672 | |
| GeneOntologyBiologicalProcess | learning | 3.03e-04 | 212 | 164 | 8 | GO:0007612 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 3.10e-04 | 41 | 164 | 4 | GO:0002474 | |
| GeneOntologyBiologicalProcess | generation of ovulation cycle rhythm | 3.73e-04 | 4 | 164 | 2 | GO:0060112 | |
| GeneOntologyBiologicalProcess | phosphatidylserine catabolic process | 3.73e-04 | 4 | 164 | 2 | GO:0006660 | |
| GeneOntologyBiologicalProcess | positive regulation of angiogenesis | 3.88e-04 | 220 | 164 | 8 | GO:0045766 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculature development | 4.24e-04 | 223 | 164 | 8 | GO:1904018 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | VLDLR FLT1 ZMPSTE24 ACADM NTRK1 GRK4 KIAA0319L ACVRL1 ZZEF1 ACE CHRNA7 GUCY2F PKD1 KCNQ1 KCNQ2 PRKCD SMPD2 IL1R1 RPE65 CHRFAM7A GPR151 ATP6V0A2 AGTRAP | 4.92e-04 | 1361 | 164 | 23 | GO:0009628 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | VLDLR FLT1 FLT3 FLT4 CRLF1 PDGFRA NTRK1 PPP1R15A CHRNA7 FZD1 CSF1R RAPGEF3 PRKCD CCR7 CHRFAM7A ALK | 5.04e-04 | 780 | 164 | 16 | GO:0042327 |
| GeneOntologyBiologicalProcess | membrane lipid metabolic process | 5.06e-04 | 229 | 164 | 8 | GO:0006643 | |
| GeneOntologyBiologicalProcess | sphingolipid metabolic process | 5.29e-04 | 176 | 164 | 7 | GO:0006665 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ZMPSTE24 MAOB SLC13A3 GRIK1 GRIK5 ACE SLC9C2 CHRNA7 SLC6A8 CLCN3 KCNQ5 SLC22A16 RAPGEF3 PKD1 KCNQ1 KCNQ2 PACC1 CCR7 ATP2A3 CHRFAM7A ATP6V0A2 GABRA2 GP1BA | 5.62e-04 | 1374 | 164 | 23 | GO:0006811 |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | VLDLR FLT1 FLT3 FLT4 PDGFRA NTRK1 CHRNA7 CSF1R PRKCD CCR7 CHRFAM7A ALK | 5.67e-04 | 490 | 164 | 12 | GO:0051347 |
| GeneOntologyBiologicalProcess | cognition | VLDLR NTRK1 ZZEF1 CHRNA7 YTHDF1 RAPGEF3 KCNQ2 SORCS3 PRKCG CHRFAM7A NPAS4 | 5.89e-04 | 423 | 164 | 11 | GO:0050890 |
| GeneOntologyBiologicalProcess | lymphangiogenesis | 5.91e-04 | 21 | 164 | 3 | GO:0001946 | |
| GeneOntologyBiologicalProcess | sensory processing | 6.19e-04 | 5 | 164 | 2 | GO:0050893 | |
| GeneOntologyBiologicalProcess | cytosol to endoplasmic reticulum transport | 6.19e-04 | 5 | 164 | 2 | GO:0046967 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 6.53e-04 | 87 | 164 | 5 | GO:0150104 | |
| GeneOntologyBiologicalProcess | memory | 6.66e-04 | 183 | 164 | 7 | GO:0007613 | |
| GeneOntologyBiologicalProcess | positive regulation of protein phosphorylation | VLDLR FLT1 FLT3 FLT4 CRLF1 PDGFRA NTRK1 PPP1R15A CHRNA7 FZD1 CSF1R RAPGEF3 PRKCD CCR7 CHRFAM7A | 6.84e-04 | 724 | 164 | 15 | GO:0001934 |
| GeneOntologyBiologicalProcess | vascular transport | 6.88e-04 | 88 | 164 | 5 | GO:0010232 | |
| GeneOntologyBiologicalProcess | vascular endothelial growth factor signaling pathway | 7.20e-04 | 51 | 164 | 4 | GO:0038084 | |
| GeneOntologyCellularComponent | receptor complex | IL12RB2 VLDLR FLT1 FLT3 FLT4 CRLF1 PDGFRA NTRK1 GRIK1 GRIK5 ACVRL1 CHRNA7 SACM1L PLA2R1 CSF1R LRP5 CHRFAM7A ALK GABRA2 GP1BA | 3.95e-08 | 581 | 166 | 20 | GO:0043235 |
| GeneOntologyCellularComponent | cell surface | MRC1 IL12RB2 VLDLR FLT3 CRLF1 PDGFRA UPK1A NTRK1 ACVRL1 ZZEF1 ACE CHRNA7 FZD1 PLA2R1 FAP CSF1R CLCN3 CLEC17A PKD1 KCNQ2 PACC1 CCR7 CLEC10A LY75 IL1R1 CHRFAM7A GP1BA | 1.99e-07 | 1111 | 166 | 27 | GO:0009986 |
| GeneOntologyCellularComponent | synaptic membrane | SEMA4B NBEA GRIK1 GRIK5 CHRNA7 FBXO2 SLC6A8 CLCN3 KCNQ5 DNM3 SORCS3 PRKCG CHRFAM7A GPR151 GABRA2 | 6.66e-05 | 583 | 166 | 15 | GO:0097060 |
| GeneOntologyCellularComponent | external side of plasma membrane | IL12RB2 FLT3 CRLF1 PDGFRA ACE CHRNA7 CLCN3 CLEC17A CCR7 CLEC10A LY75 IL1R1 CHRFAM7A GP1BA | 7.12e-05 | 519 | 166 | 14 | GO:0009897 |
| GeneOntologyCellularComponent | postsynaptic membrane | SEMA4B NBEA GRIK1 GRIK5 CHRNA7 FBXO2 SLC6A8 CLCN3 DNM3 SORCS3 CHRFAM7A GABRA2 | 9.91e-05 | 405 | 166 | 12 | GO:0045211 |
| GeneOntologyCellularComponent | spine apparatus membrane | 1.87e-04 | 3 | 166 | 2 | GO:0098897 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GRIK1 GRIK5 CHRNA7 SACM1L KCNQ5 PKD1 KCNQ1 KCNQ2 PACC1 CHRFAM7A GABRA2 | 2.26e-04 | 378 | 166 | 11 | GO:0034702 |
| GeneOntologyCellularComponent | transmembrane transporter complex | ABCA2 GRIK1 GRIK5 CHRNA7 SACM1L KCNQ5 PKD1 KCNQ1 KCNQ2 PACC1 CHRFAM7A ATP6V0A2 GABRA2 | 2.88e-04 | 523 | 166 | 13 | GO:1902495 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | PIGN EMC7 DPY19L3 ZMPSTE24 PDGFRA CYB561D2 TMTC2 PMEL PPP1R15A SCD5 DEGS1 LCLAT1 SACM1L PNPLA6 LCTL ABCB9 GUCY2F TMEM208 RPE65 ATP2A3 CYP4F11 TAP2 AGTRAP | 3.42e-04 | 1327 | 166 | 23 | GO:0042175 |
| GeneOntologyCellularComponent | basolateral part of cell | 3.72e-04 | 4 | 166 | 2 | GO:1990794 | |
| GeneOntologyCellularComponent | transporter complex | ABCA2 GRIK1 GRIK5 CHRNA7 SACM1L KCNQ5 PKD1 KCNQ1 KCNQ2 PACC1 CHRFAM7A ATP6V0A2 GABRA2 | 4.64e-04 | 550 | 166 | 13 | GO:1990351 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | PIGN EMC7 DPY19L3 ZMPSTE24 PDGFRA CYB561D2 TMTC2 PMEL PPP1R15A SCD5 DEGS1 LCLAT1 SACM1L PNPLA6 LCTL ABCB9 TMEM208 RPE65 ATP2A3 CYP4F11 TAP2 AGTRAP | 5.95e-04 | 1293 | 166 | 22 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | PIGN EMC7 DPY19L3 ZMPSTE24 PDGFRA CYB561D2 TMTC2 PMEL PPP1R15A SCD5 DEGS1 LCLAT1 SACM1L PNPLA6 LCTL ABCB9 TMEM208 RPE65 ATP2A3 CYP4F11 TAP2 AGTRAP | 6.33e-04 | 1299 | 166 | 22 | GO:0098827 |
| GeneOntologyCellularComponent | cholinergic synapse | 6.78e-04 | 22 | 166 | 3 | GO:0098981 | |
| GeneOntologyCellularComponent | axon | DPYSL3 ACADM PDGFRA NTRK1 GRIK1 GRIK5 CHRNA7 CLCN3 KCNQ5 RAPGEF3 DNM3 KCNQ2 PRKCG IL1R1 CHRFAM7A ALK GABRA2 | 7.51e-04 | 891 | 166 | 17 | GO:0030424 |
| GeneOntologyCellularComponent | basal part of cell | CA12 SLC13A3 ACE ABCA8 SLC7A1 FAP SLC14A1 RAPGEF3 PKD1 KCNQ1 | 9.09e-04 | 378 | 166 | 10 | GO:0045178 |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 9.21e-04 | 6 | 166 | 2 | GO:0032983 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.15e-03 | 201 | 166 | 7 | GO:0099634 | |
| GeneOntologyCellularComponent | potassium channel complex | 1.45e-03 | 104 | 166 | 5 | GO:0034705 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | ABCA2 GJB4 GRIK1 GRIK5 ACVRL1 CHRNA7 SACM1L KCNQ5 KCNQ1 KCNQ2 LRP5 C5 GJB7 CHRFAM7A GP1BA | 1.52e-03 | 785 | 166 | 15 | GO:0098797 |
| GeneOntologyCellularComponent | side of membrane | IL12RB2 FLT3 CRLF1 PDGFRA ACE CHRNA7 JAK1 CLCN3 CLEC17A KCNQ1 CCR7 CLEC10A LY75 IL1R1 CHRFAM7A GP1BA | 1.67e-03 | 875 | 166 | 16 | GO:0098552 |
| GeneOntologyCellularComponent | lateral part of cell | 1.70e-03 | 8 | 166 | 2 | GO:0097574 | |
| GeneOntologyCellularComponent | membrane protein complex | EMC7 ABCA2 GJB4 GRIK1 GRIK5 ACVRL1 CHRNA7 SACM1L CISH KCNQ5 PKD1 AGK KCNQ1 KCNQ2 LRP5 PACC1 C5 GJB7 CHRFAM7A TAP2 ATP6V0A2 GABRA2 GP1BA | 1.76e-03 | 1498 | 166 | 23 | GO:0098796 |
| GeneOntologyCellularComponent | basal plasma membrane | 2.14e-03 | 354 | 166 | 9 | GO:0009925 | |
| GeneOntologyCellularComponent | spine apparatus | 2.18e-03 | 9 | 166 | 2 | GO:0097444 | |
| GeneOntologyCellularComponent | endosome | MRC1 FLT1 FLT3 ABCA2 ZMPSTE24 NTRK1 MPEG1 APOC3 PMEL ACE IFNAR1 JAK1 CLCN3 ABCB9 PRF1 KCNQ1 PRKCD ATP6V0A2 EPHA3 | 2.36e-03 | 1167 | 166 | 19 | GO:0005768 |
| GeneOntologyCellularComponent | apical part of cell | CA12 VLDLR UPK1A CHRNA7 SLC6A8 SLC7A1 FAP CLCN3 RAPGEF3 KCNQ1 CHRFAM7A CYP4F11 | 2.79e-03 | 592 | 166 | 12 | GO:0045177 |
| GeneOntologyCellularComponent | cell body | DPYSL3 MAOB NTRK1 GRK4 GRIK1 GRIK5 ACVRL1 CHRNA7 BPTF CSF1R RAPGEF3 KCNQ1 RPE65 CHRFAM7A ALK GABRA2 | 3.03e-03 | 929 | 166 | 16 | GO:0044297 |
| Domain | Tyr_kinase_cat_dom | FLT1 FLT3 FLT4 PDGFRA MATK NTRK1 JAK1 CSF1R CSK MAP3K9 MAP3K21 ALK EPHA3 | 5.64e-13 | 88 | 160 | 13 | IPR020635 |
| Domain | TyrKc | FLT1 FLT3 FLT4 PDGFRA MATK NTRK1 JAK1 CSF1R CSK MAP3K9 MAP3K21 ALK EPHA3 | 5.64e-13 | 88 | 160 | 13 | SM00219 |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | FLT1 FLT3 FLT4 PDGFRA MATK NTRK1 ACVRL1 JAK1 CSF1R CSK GUCY2F MAP3K9 MAP3K21 ALK EPHA3 | 8.88e-13 | 138 | 160 | 15 | IPR001245 |
| Domain | Pkinase_Tyr | FLT1 FLT3 FLT4 PDGFRA MATK NTRK1 ACVRL1 JAK1 CSF1R CSK GUCY2F MAP3K21 ALK EPHA3 | 5.38e-12 | 129 | 160 | 14 | PF07714 |
| Domain | PROTEIN_KINASE_TYR | 6.81e-10 | 97 | 160 | 11 | PS00109 | |
| Domain | Tyr_kinase_AS | 6.81e-10 | 97 | 160 | 11 | IPR008266 | |
| Domain | Tyr_kinase_rcpt_3_CS | 2.38e-09 | 8 | 160 | 5 | IPR001824 | |
| Domain | RECEPTOR_TYR_KIN_III | 2.38e-09 | 8 | 160 | 5 | PS00240 | |
| Domain | Protein_kinase_ATP_BS | FLT1 FLT3 FLT4 PDGFRA MATK NTRK1 GRK4 ACVRL1 JAK1 STK32A CSF1R CSK MAP3K9 PRKCD PRKCG MAP3K21 ALK EPHA3 | 4.50e-09 | 379 | 160 | 18 | IPR017441 |
| Domain | Prot_kinase_dom | FLT1 FLT3 FLT4 PDGFRA MATK NTRK1 GRK4 ACVRL1 JAK1 STK32A CSF1R CSK GUCY2F MAP3K9 PRKCD PRKCG MAP3K21 ALK RPS6KL1 EPHA3 | 7.58e-09 | 489 | 160 | 20 | IPR000719 |
| Domain | Kinase-like_dom | FLT1 FLT3 FLT4 PDGFRA MATK NTRK1 GRK4 ACVRL1 JAK1 STK32A CSF1R CSK GUCY2F DNM3 MAP3K9 PRKCD PRKCG MAP3K21 ALK RPS6KL1 EPHA3 | 8.01e-09 | 542 | 160 | 21 | IPR011009 |
| Domain | PROTEIN_KINASE_DOM | FLT1 FLT3 FLT4 PDGFRA MATK NTRK1 GRK4 ACVRL1 JAK1 STK32A CSF1R CSK GUCY2F MAP3K9 PRKCD PRKCG MAP3K21 ALK RPS6KL1 EPHA3 | 8.69e-09 | 493 | 160 | 20 | PS50011 |
| Domain | PROTEIN_KINASE_ATP | FLT1 FLT3 FLT4 PDGFRA MATK NTRK1 GRK4 ACVRL1 JAK1 STK32A CSF1R CSK MAP3K9 PRKCD PRKCG MAP3K21 ALK RPS6KL1 EPHA3 | 1.53e-08 | 459 | 160 | 19 | PS00107 |
| Domain | PKD | 1.92e-08 | 11 | 160 | 5 | PS50093 | |
| Domain | PKD_dom | 1.92e-08 | 11 | 160 | 5 | IPR000601 | |
| Domain | - | 1.92e-08 | 11 | 160 | 5 | 2.60.40.670 | |
| Domain | PKD | 1.78e-07 | 7 | 160 | 4 | PF00801 | |
| Domain | CTDL_fold | 3.47e-07 | 107 | 160 | 9 | IPR016187 | |
| Domain | Lectin_C | 6.11e-07 | 84 | 160 | 8 | PF00059 | |
| Domain | CLECT | 6.11e-07 | 84 | 160 | 8 | SM00034 | |
| Domain | PKD/Chitinase_dom | 6.32e-07 | 9 | 160 | 4 | IPR022409 | |
| Domain | PKD | 6.32e-07 | 9 | 160 | 4 | SM00089 | |
| Domain | C_TYPE_LECTIN_2 | 6.70e-07 | 85 | 160 | 8 | PS50041 | |
| Domain | C-type_lectin-like | 7.33e-07 | 86 | 160 | 8 | IPR001304 | |
| Domain | C-type_lectin-like/link | 2.15e-06 | 99 | 160 | 8 | IPR016186 | |
| Domain | C_TYPE_LECTIN_1 | 5.58e-06 | 80 | 160 | 7 | PS00615 | |
| Domain | K_chnl_volt-dep_KCNQ_C | 6.09e-06 | 5 | 160 | 3 | IPR013821 | |
| Domain | K_chnl_volt-dep_KCNQ | 6.09e-06 | 5 | 160 | 3 | IPR003937 | |
| Domain | KCNQ_channel | 6.09e-06 | 5 | 160 | 3 | PF03520 | |
| Domain | Tyr_kinase_CSF1/PDGF_rcpt | 1.21e-05 | 6 | 160 | 3 | IPR016243 | |
| Domain | - | 2.00e-05 | 97 | 160 | 7 | 3.10.100.10 | |
| Domain | C-type_lectin_CS | 3.21e-05 | 43 | 160 | 5 | IPR018378 | |
| Domain | - | 3.81e-05 | 73 | 160 | 6 | 2.60.120.260 | |
| Domain | ABC_tran | 5.51e-05 | 48 | 160 | 5 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 5.51e-05 | 48 | 160 | 5 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 6.10e-05 | 49 | 160 | 5 | PS00211 | |
| Domain | ABC_transporter-like | 6.73e-05 | 50 | 160 | 5 | IPR003439 | |
| Domain | Transform_prot_C-ets | 7.29e-05 | 2 | 160 | 2 | IPR016311 | |
| Domain | K_chnl_volt-dep_KCNQ2 | 7.29e-05 | 2 | 160 | 2 | IPR003947 | |
| Domain | ABC_A | 1.28e-04 | 12 | 160 | 3 | IPR026082 | |
| Domain | Galactose-bd-like | 1.57e-04 | 94 | 160 | 6 | IPR008979 | |
| Domain | FN_type2_col-bd | 2.10e-04 | 14 | 160 | 3 | IPR000562 | |
| Domain | FN2_2 | 2.10e-04 | 14 | 160 | 3 | PS51092 | |
| Domain | FN2_1 | 2.10e-04 | 14 | 160 | 3 | PS00023 | |
| Domain | fn2 | 2.10e-04 | 14 | 160 | 3 | PF00040 | |
| Domain | FN2 | 2.10e-04 | 14 | 160 | 3 | SM00059 | |
| Domain | Flavin_amine_oxidase | 2.18e-04 | 3 | 160 | 2 | IPR001613 | |
| Domain | Cat_AA_permease | 2.18e-04 | 3 | 160 | 2 | IPR004755 | |
| Domain | ANF_lig-bd_rcpt | 2.75e-04 | 37 | 160 | 4 | IPR001828 | |
| Domain | ANF_receptor | 2.75e-04 | 37 | 160 | 4 | PF01094 | |
| Domain | Peripla_BP_I | 3.38e-04 | 39 | 160 | 4 | IPR028082 | |
| Domain | MLK1/MLK2/MLK4 | 4.33e-04 | 4 | 160 | 2 | IPR016231 | |
| Domain | MAP3K10 | 4.33e-04 | 4 | 160 | 2 | IPR015785 | |
| Domain | CAT3 | 7.17e-04 | 5 | 160 | 2 | IPR015606 | |
| Domain | AA_permease_C | 7.17e-04 | 5 | 160 | 2 | PF13906 | |
| Domain | Sortilin_C | 7.17e-04 | 5 | 160 | 2 | PF15901 | |
| Domain | Sortilin-Vps10 | 7.17e-04 | 5 | 160 | 2 | PF15902 | |
| Domain | VPS10 | 7.17e-04 | 5 | 160 | 2 | IPR006581 | |
| Domain | Sortilin_N | 7.17e-04 | 5 | 160 | 2 | IPR031778 | |
| Domain | Sortilin_C | 7.17e-04 | 5 | 160 | 2 | IPR031777 | |
| Domain | VPS10 | 7.17e-04 | 5 | 160 | 2 | SM00602 | |
| Domain | CAT_C | 7.17e-04 | 5 | 160 | 2 | IPR029485 | |
| Domain | LDLRA_1 | 7.53e-04 | 48 | 160 | 4 | PS01209 | |
| Domain | LDLRA_2 | 8.14e-04 | 49 | 160 | 4 | PS50068 | |
| Domain | PH_BEACH | 1.07e-03 | 6 | 160 | 2 | PF14844 | |
| Domain | PKD/REJ-like | 1.07e-03 | 6 | 160 | 2 | IPR002859 | |
| Domain | REJ | 1.07e-03 | 6 | 160 | 2 | PF02010 | |
| Domain | APC_su10/DOC_dom | 1.49e-03 | 7 | 160 | 2 | IPR004939 | |
| Domain | DOC | 1.49e-03 | 7 | 160 | 2 | PS51284 | |
| Domain | MACPF_2 | 1.49e-03 | 7 | 160 | 2 | PS51412 | |
| Domain | MACPF_1 | 1.49e-03 | 7 | 160 | 2 | PS00279 | |
| Domain | ANAPC10 | 1.49e-03 | 7 | 160 | 2 | PF03256 | |
| Domain | APC10 | 1.49e-03 | 7 | 160 | 2 | SM01337 | |
| Domain | ETS_DOMAIN_1 | 1.73e-03 | 28 | 160 | 3 | PS00345 | |
| Domain | ETS_DOMAIN_2 | 1.73e-03 | 28 | 160 | 3 | PS00346 | |
| Domain | Ets | 1.73e-03 | 28 | 160 | 3 | PF00178 | |
| Domain | RICIN | 1.73e-03 | 28 | 160 | 3 | SM00458 | |
| Domain | ETS | 1.73e-03 | 28 | 160 | 3 | SM00413 | |
| Domain | Ets_dom | 1.73e-03 | 28 | 160 | 3 | IPR000418 | |
| Domain | ETS_DOMAIN_3 | 1.73e-03 | 28 | 160 | 3 | PS50061 | |
| Domain | RICIN_B_LECTIN | 1.73e-03 | 28 | 160 | 3 | PS50231 | |
| Domain | FA_desaturase_dom | 1.97e-03 | 8 | 160 | 2 | IPR005804 | |
| Domain | FA_desaturase | 1.97e-03 | 8 | 160 | 2 | PF00487 | |
| Domain | PH-BEACH_dom | 1.97e-03 | 8 | 160 | 2 | IPR023362 | |
| Domain | - | 1.97e-03 | 8 | 160 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 1.97e-03 | 8 | 160 | 2 | PS51783 | |
| Domain | Ricin_B_lectin | 2.11e-03 | 30 | 160 | 3 | IPR000772 | |
| Domain | BEACH | 2.52e-03 | 9 | 160 | 2 | PS50197 | |
| Domain | Beach | 2.52e-03 | 9 | 160 | 2 | PF02138 | |
| Domain | - | 2.52e-03 | 9 | 160 | 2 | 1.10.1540.10 | |
| Domain | Beach | 2.52e-03 | 9 | 160 | 2 | SM01026 | |
| Domain | Sialidases | 2.52e-03 | 9 | 160 | 2 | IPR011040 | |
| Domain | BEACH_dom | 2.52e-03 | 9 | 160 | 2 | IPR000409 | |
| Domain | Kringle-like | 2.55e-03 | 32 | 160 | 3 | IPR013806 | |
| Domain | CNMP_BINDING_1 | 2.55e-03 | 32 | 160 | 3 | PS00888 | |
| Domain | CNMP_BINDING_2 | 2.55e-03 | 32 | 160 | 3 | PS00889 | |
| Domain | VG_K_chnl | 2.79e-03 | 33 | 160 | 3 | IPR028325 | |
| Domain | cNMP | 3.04e-03 | 34 | 160 | 3 | SM00100 | |
| Domain | cNMP_binding | 3.04e-03 | 34 | 160 | 3 | PF00027 | |
| Domain | Amino_oxidase | 3.14e-03 | 10 | 160 | 2 | IPR002937 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 4.95e-08 | 25 | 119 | 6 | M47934 | |
| Pathway | WP_RAS_SIGNALING | FLT1 FLT3 FLT4 PDGFRA NTRK1 ETS1 ETS2 PLA2G4D CSF1R PRKCG EXOC2 | 4.31e-07 | 184 | 119 | 11 | M39764 |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 1.70e-06 | 98 | 119 | 8 | M39830 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 3.29e-05 | 44 | 119 | 5 | M11911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY | 7.09e-05 | 83 | 119 | 6 | M47961 | |
| Pathway | KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION | IL12RB2 FLT1 FLT3 FLT4 PDGFRA ACVRL1 IFNAR1 CSF1R CCR7 IL1R1 | 7.93e-05 | 264 | 119 | 10 | M9809 |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY | 1.05e-04 | 89 | 119 | 6 | M47963 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY | 1.26e-04 | 92 | 119 | 6 | M47927 | |
| Pathway | WP_CANCER_PATHWAYS | IL12RB2 FLT3 FLT4 PDGFRA NTRK1 ETS1 IFNAR1 FZD1 JAK1 CSF1R LRP5 PRKCG ALK | 3.47e-04 | 507 | 119 | 13 | M48302 |
| Pathway | BIOCARTA_ETS_PATHWAY | 3.66e-04 | 17 | 119 | 3 | M14449 | |
| Pathway | BIOCARTA_ETS_PATHWAY | 3.66e-04 | 17 | 119 | 3 | MM1435 | |
| Pubmed | 2.87e-13 | 83 | 168 | 11 | 11114734 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | CA12 PIGN SEMA4B SUMF2 DPYSL3 EMC7 ABCA2 DPY19L3 CRLF1 ZMPSTE24 QPCTL KIAA0319L TMTC2 TM2D3 ZZEF1 DEGS1 SACM1L SLC6A8 PLA2R1 FAP TMEM245 LRP5 PACC1 ATP2A3 TAP2 ATP6V0A2 | 1.61e-10 | 1201 | 168 | 26 | 35696571 |
| Pubmed | 3.89e-08 | 40 | 168 | 6 | 30898150 | ||
| Pubmed | Identification of tyrosine kinases expressed in the male mouse gubernaculum during development. | 1.22e-07 | 25 | 168 | 5 | 15254900 | |
| Pubmed | 3.35e-07 | 186 | 168 | 9 | 20673868 | ||
| Pubmed | 3.35e-07 | 186 | 168 | 9 | 20452482 | ||
| Pubmed | Genetic influences on blood pressure within the Stanislas Cohort. | 3.63e-07 | 13 | 168 | 4 | 15076187 | |
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 8981363 | ||
| Pubmed | 5.06e-07 | 14 | 168 | 4 | 26720279 | ||
| Pubmed | 6.88e-07 | 15 | 168 | 4 | 11341749 | ||
| Pubmed | 6.91e-07 | 64 | 168 | 6 | 19729601 | ||
| Pubmed | 7.27e-07 | 103 | 168 | 7 | 11752456 | ||
| Pubmed | The contribution of Kv7 channels to pregnant mouse and human myometrial contractility. | 1.10e-06 | 5 | 168 | 3 | 20132415 | |
| Pubmed | Inflammation induces two types of inflammatory dendritic cells in inflamed lymph nodes. | 1.10e-06 | 5 | 168 | 3 | 29546878 | |
| Pubmed | Integrative predictive model of coronary artery calcification in atherosclerosis. | 1.90e-06 | 229 | 168 | 9 | 19948975 | |
| Pubmed | Two distinct protein isoforms are encoded by ntk, a csk-related tyrosine protein kinase gene. | 2.19e-06 | 6 | 168 | 3 | 7970703 | |
| Pubmed | A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms. | 3.82e-06 | 7 | 168 | 3 | 19506579 | |
| Pubmed | 3.82e-06 | 7 | 168 | 3 | 18270328 | ||
| Pubmed | 6.52e-06 | 143 | 168 | 7 | 20424473 | ||
| Pubmed | 8.47e-06 | 57 | 168 | 5 | 19263529 | ||
| Pubmed | 9.10e-06 | 9 | 168 | 3 | 16420563 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.01e-05 | 101 | 168 | 6 | 23382219 | |
| Pubmed | 1.09e-05 | 60 | 168 | 5 | 12082592 | ||
| Pubmed | Genetic predisposition to thrombophilia in inflammatory bowel disease. | 1.30e-05 | 10 | 168 | 3 | 20717043 | |
| Pubmed | 1.30e-05 | 10 | 168 | 3 | 18162309 | ||
| Pubmed | Regulation of lymphangiogenesis in the diaphragm by macrophages and VEGFR-3 signaling. | 1.30e-05 | 10 | 168 | 3 | 27464987 | |
| Pubmed | 1.30e-05 | 10 | 168 | 3 | 20080755 | ||
| Pubmed | VLDLR CRLF1 DPH7 NBEA SLC13A3 MS4A10 JAK1 STK32A SLC6A8 FAP TAS1R1 C5 GJB7 SLX4 EPHA3 | 1.38e-05 | 832 | 168 | 15 | 36724073 | |
| Pubmed | Genetic mutations associated with cigarette smoking in pancreatic cancer. | 1.39e-05 | 63 | 168 | 5 | 19351817 | |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | 1.46e-05 | 372 | 168 | 10 | 22939624 | |
| Pubmed | 1.48e-05 | 108 | 168 | 6 | 19956635 | ||
| Pubmed | 1.50e-05 | 64 | 168 | 5 | 19131662 | ||
| Pubmed | Endothelial Cyp26b1 restrains murine heart valve growth during development. | 1.53e-05 | 163 | 168 | 7 | 35364055 | |
| Pubmed | Murine txk: a protein tyrosine kinase gene regulated by T cell activation. | 1.70e-05 | 32 | 168 | 4 | 7542761 | |
| Pubmed | Protein kinase Cdelta regulates apoptosis via activation of STAT1. | 1.78e-05 | 11 | 168 | 3 | 15322115 | |
| Pubmed | Nutrigenetics: links between genetic background and response to Mediterranean-type diets. | 1.78e-05 | 11 | 168 | 3 | 19689828 | |
| Pubmed | Reduced mTORC1-signaling in retinal ganglion cells leads to vascular retinopathy. | 1.78e-05 | 11 | 168 | 3 | 34148274 | |
| Pubmed | Characterization of single-nucleotide polymorphisms in coding regions of human genes. | 1.88e-05 | 67 | 168 | 5 | 10391209 | |
| Pubmed | 2.17e-05 | 172 | 168 | 7 | 27375898 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 34453977 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 11122103 | ||
| Pubmed | Sensorimotor gating and spatial learning in α7-nicotinic receptor knockout mice. | 2.32e-05 | 2 | 168 | 2 | 23521765 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 28258105 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 19344760 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24594380 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 19657584 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 29114104 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24836856 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 15948184 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 35678315 | ||
| Pubmed | Functional role of alpha7 nicotinic receptor in physiological control of cutaneous homeostasis. | 2.32e-05 | 2 | 168 | 2 | 12628457 | |
| Pubmed | Cognitive abnormalities and hippocampal alterations in monoamine oxidase A and B knockout mice. | 2.32e-05 | 2 | 168 | 2 | 23858446 | |
| Pubmed | Prenatal nicotine exposure alters lung function and airway geometry through α7 nicotinic receptors. | 2.32e-05 | 2 | 168 | 2 | 22246862 | |
| Pubmed | SORCS1 and SORCS3 control energy balance and orexigenic peptide production. | 2.32e-05 | 2 | 168 | 2 | 29440124 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 21075085 | ||
| Pubmed | Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation. | 2.32e-05 | 2 | 168 | 2 | 15890649 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 25398695 | ||
| Pubmed | Transcriptional regulation and multiple functions of MAO genes. | 2.32e-05 | 2 | 168 | 2 | 21359973 | |
| Pubmed | Eight genes are highly associated with BMD variation in postmenopausal Caucasian women. | 2.32e-05 | 2 | 168 | 2 | 19922823 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 1400473 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 26937017 | ||
| Pubmed | Identification and characterization of a TAP-family gene in the lamprey. | 2.32e-05 | 2 | 168 | 2 | 12679854 | |
| Pubmed | Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. | 2.32e-05 | 2 | 168 | 2 | 16650968 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24462939 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 29261717 | ||
| Pubmed | Altered hippocampal circuit function in C3H alpha7 null mutant heterozygous mice. | 2.32e-05 | 2 | 168 | 2 | 18199426 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 11596779 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 18077004 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 19462340 | ||
| Pubmed | ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm. | 2.32e-05 | 2 | 168 | 2 | 18958307 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 11790782 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 11861643 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 37746145 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 19631623 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 15770102 | ||
| Pubmed | Alpha 7 subunit of nAChR regulates migration of human mesenchymal stem cells. | 2.32e-05 | 2 | 168 | 2 | 20720594 | |
| Pubmed | Monoamine oxidase A and A/B knockout mice display autistic-like features. | 2.32e-05 | 2 | 168 | 2 | 22850464 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 17427196 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 18092818 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 20589923 | ||
| Pubmed | Chrna7 genotype is linked with alpha7 nicotinic receptor expression but not alpha7 RNA levels. | 2.32e-05 | 2 | 168 | 2 | 19368846 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 34514543 | ||
| Pubmed | Remodeling of Kv7.1 and Kv7.5 Expression in Vascular Tumors. | 2.32e-05 | 2 | 168 | 2 | 32825637 | |
| Pubmed | Signal 3 requirement for memory CD8+ T-cell activation is determined by the infectious pathogen. | 2.32e-05 | 2 | 168 | 2 | 21830209 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 22183893 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 12606407 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 21697081 | ||
| Pubmed | Nicotine elicits prolonged calcium signaling along ventral hippocampal axons. | 2.32e-05 | 2 | 168 | 2 | 24349346 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 10329710 | ||
| Pubmed | Cholinergic modulation of appetite-related synapses in mouse lateral hypothalamic slice. | 2.32e-05 | 2 | 168 | 2 | 16319313 | |
| Pubmed | Increased baroreceptor response in mice deficient in monoamine oxidase A and B. | 2.32e-05 | 2 | 168 | 2 | 11834493 | |
| Pubmed | Impaired synaptic plasticity in the visual cortex of mice lacking α7-nicotinic receptor subunit. | 2.32e-05 | 2 | 168 | 2 | 25797465 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 29197398 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 38178134 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 3387449 | ||
| Pubmed | Site-directed mutagenesis of monoamine oxidase A and B: role of cysteines. | 2.32e-05 | 2 | 168 | 2 | 8316221 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 23325242 | ||
| Pubmed | Association between monoamine oxidase gene polymorphisms and smoking behavior: A meta-analysis. | 2.32e-05 | 2 | 168 | 2 | 26051160 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 21901321 | ||
| Pubmed | Promoter organization and activity of human monoamine oxidase (MAO) A and B genes. | 2.32e-05 | 2 | 168 | 2 | 1432104 | |
| Interaction | C3orf52 interactions | ABCA2 FLT4 QPCTL LCLAT1 PNPLA6 CLCN3 KCNQ5 ABCB9 TMEM245 SMPD2 CLEC10A ATP2A3 TAP2 | 1.17e-06 | 305 | 162 | 13 | int:C3orf52 |
| Interaction | PIK3R1 interactions | FLT1 FLT3 FLT4 ACADM PDGFRA NTRK1 AHSA1 CHRNA7 IFNAR1 JAK1 CSF1R IL1R1 ALK EPHA3 GP1BA | 1.25e-06 | 412 | 162 | 15 | int:PIK3R1 |
| Interaction | MAOB interactions | 1.55e-06 | 45 | 162 | 6 | int:MAOB | |
| Interaction | MARCHF4 interactions | 3.43e-06 | 112 | 162 | 8 | int:MARCHF4 | |
| Interaction | KCNMB3 interactions | 4.13e-06 | 53 | 162 | 6 | int:KCNMB3 | |
| Interaction | KIT interactions | 7.77e-06 | 125 | 162 | 8 | int:KIT | |
| Interaction | RXFP1 interactions | 8.13e-06 | 90 | 162 | 7 | int:RXFP1 | |
| Interaction | PGRMC2 interactions | FLT4 NTRK1 GPR182 CYB561D2 SLC6A8 PNPLA6 TMEM208 SMPD2 C5 ALK GPR151 | 1.77e-05 | 281 | 162 | 11 | int:PGRMC2 |
| Interaction | SGPP1 interactions | 3.31e-05 | 46 | 162 | 5 | int:SGPP1 | |
| Interaction | PTPN11 interactions | FLT1 FLT3 FLT4 PDGFRA NTRK1 GPX7 NEB IFNAR1 JAK1 CSF1R ALK SLX4 | 4.44e-05 | 368 | 162 | 12 | int:PTPN11 |
| Interaction | CREB3L1 interactions | CYB561D2 SLC13A3 TMEM229B SACM1L SLC7A1 TMEM208 CD72 C5 GPR151 | 4.49e-05 | 206 | 162 | 9 | int:CREB3L1 |
| Interaction | ABCA6 interactions | 5.87e-05 | 10 | 162 | 3 | int:ABCA6 | |
| Interaction | SDF2L1 interactions | SEMA4B FLT3 EMC7 ABCA2 FLT4 CRLF1 TMTC2 ERVMER34-1 PRF1 LRP5 ALK | 6.13e-05 | 322 | 162 | 11 | int:SDF2L1 |
| Interaction | ZMYND15 interactions | 6.42e-05 | 2 | 162 | 2 | int:ZMYND15 | |
| Interaction | KCNA2 interactions | 6.86e-05 | 125 | 162 | 7 | int:KCNA2 | |
| Interaction | OR4N2 interactions | 8.17e-05 | 29 | 162 | 4 | int:OR4N2 | |
| Interaction | TCTN3 interactions | EMC7 DPY19L3 ZMPSTE24 SCD5 DEGS1 LCLAT1 SLC6A8 CSK TMEM245 TAP2 ATP6V0A2 | 8.50e-05 | 334 | 162 | 11 | int:TCTN3 |
| Interaction | SLC17A2 interactions | 8.66e-05 | 56 | 162 | 5 | int:SLC17A2 | |
| Interaction | ATP2A3 interactions | 1.12e-04 | 232 | 162 | 9 | int:ATP2A3 | |
| Cytoband | 5q32 | 1.69e-06 | 54 | 168 | 5 | 5q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q32 | 1.19e-05 | 80 | 168 | 5 | chr5q32 | |
| Cytoband | 10q23-q25 | 7.95e-05 | 4 | 168 | 2 | 10q23-q25 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 6.57e-09 | 40 | 118 | 7 | 321 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | MRC1 FLT3 PDGFRA ACE CSF1R CD72 CCR7 CLEC10A LY75 IL1R1 ALK GP1BA | 1.04e-05 | 394 | 118 | 12 | 471 |
| GeneFamily | C-type lectin domain family | 1.34e-05 | 47 | 118 | 5 | 494 | |
| GeneFamily | ATP binding cassette subfamily A | 9.36e-05 | 14 | 118 | 3 | 805 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 4.17e-04 | 5 | 118 | 2 | 1199 | |
| GeneFamily | ETS transcription factor family | 7.88e-04 | 28 | 118 | 3 | 534 | |
| GeneFamily | Fatty acid desaturases | 1.15e-03 | 8 | 118 | 2 | 553 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.48e-03 | 9 | 118 | 2 | 1230 | |
| GeneFamily | Immunoglobulin like domain containing | 1.68e-03 | 193 | 118 | 6 | 594 | |
| GeneFamily | C2 domain containing protein kinases | 1.84e-03 | 10 | 118 | 2 | 835 | |
| GeneFamily | ATP binding cassette subfamily B | 2.24e-03 | 11 | 118 | 2 | 806 | |
| GeneFamily | Potassium voltage-gated channels | 2.25e-03 | 40 | 118 | 3 | 274 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.41e-03 | 41 | 118 | 3 | 1298 | |
| GeneFamily | Low density lipoprotein receptors | 3.14e-03 | 13 | 118 | 2 | 634 | |
| GeneFamily | Solute carriers | SLC13A3 SLC9C2 SLC6A8 SLC7A1 SLC7A3 SLC14A1 SLC22A16 SLC17A9 | 4.39e-03 | 395 | 118 | 8 | 752 |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 6.04e-03 | 18 | 118 | 2 | 91 | |
| GeneFamily | Gap junction proteins | 8.96e-03 | 22 | 118 | 2 | 314 | |
| GeneFamily | Abhydrolase domain containing | 8.96e-03 | 22 | 118 | 2 | 4 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN | 4.34e-08 | 32 | 164 | 6 | MM17 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN | 6.37e-08 | 34 | 164 | 6 | M45005 | |
| Coexpression | GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_DN | IL12RB2 DPYSL3 DPY19L3 TMEM212 MPEG1 GRIK1 DEGS1 DNM3 PACC1 IL1R1 | 8.45e-08 | 163 | 164 | 10 | M6722 |
| Coexpression | GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP | 5.66e-07 | 200 | 164 | 10 | M5185 | |
| Coexpression | SMID_BREAST_CANCER_NORMAL_LIKE_UP | MRC1 PDGFRA MATK ACVRL1 ABCA8 SVEP1 ABCA6 PRF1 CD72 CCR7 CLEC10A LY75 IL1R1 ATP2A3 | 2.41e-06 | 485 | 164 | 14 | M8513 |
| Coexpression | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN | 1.59e-05 | 85 | 164 | 6 | M1451 | |
| Coexpression | E2F1_UP.V1_DN | 2.44e-05 | 187 | 164 | 8 | M2630 | |
| Coexpression | GSE2585_THYMIC_MACROPHAGE_VS_MTEC_DN | 3.68e-05 | 198 | 164 | 8 | M6280 | |
| Coexpression | GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN | 3.95e-05 | 200 | 164 | 8 | M9757 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+F4/80lo.Kd, CD45+ CD11c+ I-A/I-E+ CD11b+ F4/80lo, Kidney, avg-3 | 1.94e-05 | 73 | 161 | 6 | GSM854273_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | ACER2 MRC1 FLT1 DPYSL3 FLT4 GPR182 ETS1 ETS2 MPEG1 PPP1R15A ACVRL1 CSF1R RAPGEF3 DNM3 | 4.69e-05 | 523 | 161 | 14 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k3_1000 |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.Lv, CD45+ CD11c+ MHC-II + CD11b high CD103-, Liver, avg-3 | ZMYND15 MRC1 FLT1 FLT3 FLT4 GPR182 ETS2 MPEG1 PPP1R15A CSF1R PRKCD CLEC10A | 7.33e-05 | 411 | 161 | 12 | GSM538239_500 |
| CoexpressionAtlas | cerebral cortex | CDR1 ABCA2 TMEM229A CRLF1 MATK NBEA GRIK1 GRIK5 SCD5 SYNPR FBXO2 SORCS1 KCNQ5 DNM3 KCNQ2 SORCS3 PRKCG PACC1 CREG2 RPE65 ALK RPS6KL1 NPAS4 MIR9-1HG GABRA2 | 7.48e-05 | 1428 | 161 | 25 | cerebral cortex |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | ACER2 MRC1 FLT1 DPYSL3 FLT4 PDGFRA GPR182 ETS1 ETS2 MPEG1 PPP1R15A ACVRL1 MS4A10 STK32A CSF1R RAPGEF3 DNM3 IL1R1 | 7.81e-05 | 846 | 161 | 18 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000 | ACER2 MRC1 VLDLR FLT1 EMC7 PDGFRA ETS1 NBEA ACVRL1 LYST TMEM229B PLA2R1 KCNQ5 RAPGEF3 IL1R1 ATP2A3 TAP2 EPHA3 | 1.14e-04 | 872 | 161 | 18 | gudmap_kidney_adult_Mesangium_Meis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_500 | 1.35e-04 | 65 | 161 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.56e-04 | 151 | 161 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k2 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Ectoderm_top-relative-expression-ranked_1000 | CA12 IL12RB2 FLT1 DPYSL3 UPK1A MATK NEB ACE ERVMER34-1 SLC7A1 SLC7A3 SLC17A9 DNM3 KCNQ1 KCNQ2 LY75 MAP3K21 ATP2A3 TAP2 | 1.74e-04 | 984 | 161 | 19 | PCBC_ratio_SC_vs_ECTO_1000 |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II+.Bl, CD115+ B220- CD43+ Ly6C- MHCIIhi, Blood, avg-2 | 2.05e-04 | 71 | 161 | 5 | GSM605878_100 | |
| CoexpressionAtlas | BM Top 100 - cerebral cortex | 2.19e-04 | 72 | 161 | 5 | BM Top 100 - cerebral cortex | |
| CoexpressionAtlas | BM Top 100 - frontal lobe | 2.19e-04 | 72 | 161 | 5 | BM Top 100 - frontal lobe | |
| CoexpressionAtlas | BM Top 100 - occipital lobe | 2.33e-04 | 73 | 161 | 5 | BM Top 100 - occipital lobe | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_k-means-cluster#4_top-relative-expression-ranked_100 | 2.35e-04 | 40 | 161 | 4 | gudmap_kidney_adult_RenMedVasc_Tie2_k4_100 | |
| CoexpressionAtlas | BM Top 100 - temporal lobe | 2.49e-04 | 74 | 161 | 5 | BM Top 100 - temporal lobe | |
| CoexpressionAtlas | BM Top 100 - putamen | 2.82e-04 | 76 | 161 | 5 | BM Top 100 - putamen | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 3.11e-04 | 282 | 161 | 9 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k4_500 | |
| CoexpressionAtlas | BM Top 100 - accumbens | 3.18e-04 | 78 | 161 | 5 | BM Top 100 - accumbens | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+24-.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24-, Lung, avg-2 | ZMYND15 MRC1 FLT3 ETS2 MPEG1 SLC13A3 PPP1R15A ACE CSF1R CD72 CLEC10A | 3.31e-04 | 414 | 161 | 11 | GSM854271_500 |
| CoexpressionAtlas | placenta | ACER2 IL12RB2 FLT1 CRLF1 CETP ACVRL1 ERVMER34-1 F5 SVEP1 GJB7 | 3.42e-04 | 349 | 161 | 10 | placenta |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#2_top-relative-expression-ranked_200 | 3.54e-04 | 123 | 161 | 6 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k2_200 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+24-.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24-, Lung, avg-2 | 3.79e-04 | 81 | 161 | 5 | GSM854271_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_200 | 3.99e-04 | 176 | 161 | 7 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#2_top-relative-expression-ranked_200 | 4.05e-04 | 46 | 161 | 4 | gudmap_developingLowerUrinaryTract_adult_bladder_200_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | ACER2 MRC1 FLT1 DPYSL3 FLT4 ETS1 ETS2 MPEG1 PPP1R15A ACVRL1 CSF1R RAPGEF3 DNM3 | 4.18e-04 | 570 | 161 | 13 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k3_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_200 | 4.41e-04 | 179 | 161 | 7 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_200 | |
| ToppCell | NS-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.65e-10 | 160 | 168 | 10 | 8a4746463ca1976f7d6de803496c851249ced797 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.06e-08 | 160 | 168 | 9 | c61869d9dbba250270e59366e15af204e5b4395d | |
| ToppCell | COVID-19-kidney-NK|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.08e-08 | 181 | 168 | 9 | 8906ee8a7a1616dfe8c3b5c73988416641213629 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.68e-08 | 190 | 168 | 9 | 8cb950effc449ae59a915132ecc079be54d1acfe | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.68e-08 | 190 | 168 | 9 | 5dfbd064ab1f8a0b18b5975c47f8e79697f3db15 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.68e-08 | 190 | 168 | 9 | 17a73a658fb30a4322b31e38db7b240023738f29 | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.90e-08 | 191 | 168 | 9 | 6345c1aa0fd2f9f2154a44f9393bf7c72bb1f44e | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-08 | 192 | 168 | 9 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-08 | 192 | 168 | 9 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-08 | 192 | 168 | 9 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-08 | 193 | 168 | 9 | 59b8186d0221fba06a16157e9d148399ed801f38 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-08 | 193 | 168 | 9 | dc92680b4bb9fc26430c92e03adb839c8c3b3b98 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-08 | 193 | 168 | 9 | 03678162648bd5b1d65a5450b60c8863edbf95c7 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-08 | 195 | 168 | 9 | 52b2bbf12e5f86c493f6634697aeb23a68cc916d | |
| ToppCell | facs-Lung-ENDOMUCIN-18m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.12e-08 | 196 | 168 | 9 | f6df26ab9eebae893768a4f70a064ce9f60da93c | |
| ToppCell | facs-Lung-ENDOMUCIN|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.12e-08 | 196 | 168 | 9 | 69f03546c42c942ab8ac8746167c8d44d574b4c6 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-08 | 197 | 168 | 9 | d584d0334ea97e3fa8c4cd869f5eeea2c7a1ed04 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-08 | 197 | 168 | 9 | 412091994196a06c2779b4c2cfed84be889a5f8d | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 6.67e-08 | 198 | 168 | 9 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.97e-08 | 199 | 168 | 9 | 514dbf128b6832b1cbd65be023d4fe02400e8dec | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-NK_CD56bright|URO / Disease, condition lineage and cell class | 7.27e-08 | 200 | 168 | 9 | 2fff822145ec298445595ba64334e6a1db8254f4 | |
| ToppCell | facs-MAT-Fat-18m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-07 | 167 | 168 | 8 | c2952d8ba763374c5678b92825c8956fc3e3ecd2 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.51e-07 | 181 | 168 | 8 | c7a220891567c7539ad5a9ac9db375f0de08ea00 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.26e-07 | 189 | 168 | 8 | 3e148accffc6ab249fb0dff7f3bf5a7fff9da773 | |
| ToppCell | (0)_Normal/No_Treatment-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 6.52e-07 | 190 | 168 | 8 | ff083168d609957d00888f31b3488d6d56c902b4 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.52e-07 | 190 | 168 | 8 | 9d5242759546be0089981ef1877e4ed5f81face5 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.05e-07 | 192 | 168 | 8 | bcd8876235be503186f119653b39476488c0fa15 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.05e-07 | 192 | 168 | 8 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.05e-07 | 192 | 168 | 8 | f4cd65e6c5b17bcabf45fe5b687246c72e7975f7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.34e-07 | 193 | 168 | 8 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.34e-07 | 193 | 168 | 8 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | (4)_Endothelial_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 7.34e-07 | 193 | 168 | 8 | ae6ba13d4d9f2a700887cdda2790c32007b29ac8 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-|bone_marrow / Manually curated celltypes from each tissue | 7.63e-07 | 194 | 168 | 8 | 5c58a2d1dd3c8ff77ce44d473239685e6b020909 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.93e-07 | 195 | 168 | 8 | e5f14f6015ea5e6fa065f906ad22157e3de15c68 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-NK_cell-NK-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.93e-07 | 195 | 168 | 8 | 234666fb7a1fd7e33bb7e54fd4004649ce22de70 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-NK_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.93e-07 | 195 | 168 | 8 | c7743d8c57584d29cca69c6405f1df6718174582 | |
| ToppCell | -Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 7.93e-07 | 195 | 168 | 8 | e5b0afbea85575851cf9eb50a9ac42c67bbf3d7c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.93e-07 | 195 | 168 | 8 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.93e-07 | 195 | 168 | 8 | 5b84fd5be31386eb1d6048bbf28626032361842e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-NK_cell-NK|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.93e-07 | 195 | 168 | 8 | f0fb039f3d2e36acb258afb8b6d2fed20c395c36 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-07 | 196 | 168 | 8 | 81900dcc9451ff6606ec940c16b559d73247590e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.56e-07 | 197 | 168 | 8 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.89e-07 | 198 | 168 | 8 | e1fa02184ce93c4f8aa5cf04b70949cd4c425ff0 | |
| ToppCell | Sigmoid-(5)_Dendritic_cell-(50)_cDC2|Sigmoid / shred on region, Cell_type, and subtype | 9.24e-07 | 199 | 168 | 8 | 402af84db90d8a49d67cf44c24766aefb00fd716 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.24e-07 | 199 | 168 | 8 | 236b1417ed0875e98c6ec1ec714003bfce438d65 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.24e-07 | 199 | 168 | 8 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial|World / Primary Cells by Cluster | 9.24e-07 | 199 | 168 | 8 | b9763ac9857a60db6f1f104fe1e9ea2266cf931b | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial-Endothelial-24|World / Primary Cells by Cluster | 9.24e-07 | 199 | 168 | 8 | 0b4edf3e359749827ef978a77b5267ddde732d71 | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial-Endothelial|World / Primary Cells by Cluster | 9.24e-07 | 199 | 168 | 8 | 9e01eee126247a0696c71b019f855a8a41a0ede3 | |
| ToppCell | Sigmoid-Dendritic_cell-cDC2|Sigmoid / Region, Cell class and subclass | 9.24e-07 | 199 | 168 | 8 | cd74db6db694b68f81dcf9d9342d125d00357ec1 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.59e-07 | 200 | 168 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Caecum-Dendritic_cell|Caecum / Region, Cell class and subclass | 9.59e-07 | 200 | 168 | 8 | b91d3d7505a022ca360ab5b3f9955753d111f974 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 9.59e-07 | 200 | 168 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Caecum-(5)_Dendritic_cell|Caecum / shred on region, Cell_type, and subtype | 9.59e-07 | 200 | 168 | 8 | aa87810706fd4164085d8e973359b68a2691842e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.59e-07 | 200 | 168 | 8 | 061ba851f941c616ddb462512e826c412881c3ce | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.59e-07 | 138 | 168 | 7 | c172880eda7b8b8b758dbbc77f93191238f3181c | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.01e-06 | 139 | 168 | 7 | 313f7e66ed94950129c7146a2afe2feb8951fe1e | |
| ToppCell | URO-Lymphocyte-T_NK-NK_CD56bright|URO / Disease, Lineage and Cell Type | 1.47e-06 | 147 | 168 | 7 | a6ca90e8dc37a016572ff68f34ab227b020eef70 | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-mDC|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-06 | 147 | 168 | 7 | 26bd9d89e2e7b841cc18030bb7cebb642b987183 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-interstitial_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.37e-06 | 158 | 168 | 7 | 9a6d9b541446a6aa9f8ed040b330dbb5c6447076 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.37e-06 | 158 | 168 | 7 | 2438713d2a7e32c647ab3384237ed614f4ec8fec | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-06 | 159 | 168 | 7 | cdbccb83af6220bab300dfe56443ff69f6e2043a | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Tem/emra_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.92e-06 | 163 | 168 | 7 | 1a8c79903ed416f286ebe8a9922233affbc55d82 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.16e-06 | 165 | 168 | 7 | c042cde64b61ae195e1054f7b560151dabbfdf0d | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-mDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.56e-06 | 168 | 168 | 7 | 2dca1c4a33b6da9357fa3b2a523af19baab1c21c | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.70e-06 | 169 | 168 | 7 | 606aa4ff25380d9470ec116ca86cd20f8b19587a | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.70e-06 | 169 | 168 | 7 | 052aae2af5446a0de071d5dda5381b0b9a0ed54d | |
| ToppCell | COVID-19_Moderate-NK_CD56bright|World / disease group, cell group and cell class | 3.85e-06 | 170 | 168 | 7 | caa6a534c1e9639caced9a51680f5c905f061bcc | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.16e-06 | 172 | 168 | 7 | f0e767a20d93e546ce278db67dbd779cc68af533 | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-mDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.16e-06 | 172 | 168 | 7 | cc0e2a45fa74ee19e41612c3615729462474003a | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.16e-06 | 172 | 168 | 7 | 1abb6fbb28c8aff384540493d0f70eeacaa751f4 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.16e-06 | 172 | 168 | 7 | 422d311bba2dd5d8bece4e96ee8c86e78086b62d | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-06 | 172 | 168 | 7 | 979fd7b435f59b8a4d290a809cf76147d4c63d48 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-06 | 172 | 168 | 7 | f4d7f416802218ce56408fa4cb8a555d846bc85b | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.27e-06 | 112 | 168 | 6 | 9801227fe5a6f5ae1b6c5a9e7fa7f35c4c52efe1 | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.32e-06 | 173 | 168 | 7 | b335ca2a247156eba821943b2b9fc9922230b409 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-06 | 173 | 168 | 7 | 6d2ceba4f89a228600e2b40aba81bb0eb81578c0 | |
| ToppCell | COVID-19_Moderate-NK_CD56bright|COVID-19_Moderate / disease group, cell group and cell class | 4.32e-06 | 173 | 168 | 7 | a07dcb1e555caaa2235aec219334fcbf2d07f10c | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.66e-06 | 175 | 168 | 7 | 2eca4c168dea2017ea0e383006e28abed22f32ec | |
| ToppCell | Healthy_Control-Myeloid-Mast-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.66e-06 | 175 | 168 | 7 | eadbbcdf2aef4cee268bc70a7a2c4175d898953b | |
| ToppCell | Healthy_Control-Myeloid-Mast|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.66e-06 | 175 | 168 | 7 | ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.84e-06 | 176 | 168 | 7 | f3bbe8c1a8d132705eac360cf531261271d84588 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-06 | 176 | 168 | 7 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-06 | 176 | 168 | 7 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.02e-06 | 177 | 168 | 7 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.02e-06 | 177 | 168 | 7 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-06 | 177 | 168 | 7 | 8ef41ee5d63737b810ad7371b0437625e7e1badf | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.21e-06 | 178 | 168 | 7 | e86ed30652c2de70f16430f04b78789b87df4af2 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.61e-06 | 180 | 168 | 7 | 755050226eeb1991ee7f0d15e39d0458f3e4a791 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.81e-06 | 181 | 168 | 7 | 03a303cd2f366f09c18b118bbba6f5e3f95ad56c | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-06 | 181 | 168 | 7 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.81e-06 | 181 | 168 | 7 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.81e-06 | 181 | 168 | 7 | 9c4f9abb9335da2b07644bca8faff1baa1bb9f5b | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-06 | 182 | 168 | 7 | dc55de945c6f78f32eb3a1b3520835eb8417e068 | |
| ToppCell | P28-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.03e-06 | 182 | 168 | 7 | db5d6c5e7d59734653906b126f2c1d57461a5290 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.03e-06 | 182 | 168 | 7 | 7af3b2029b7f55b923d5a4b764d4292f4ea48599 | |
| ToppCell | E18.5-samps-Endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.03e-06 | 182 | 168 | 7 | e2d799e6e7526176a6fe6515b8fbe4d83d3a3ea1 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-06 | 182 | 168 | 7 | 010a7364da46101cb5068891fd7bc712ea8f13bd | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.03e-06 | 182 | 168 | 7 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-06 | 183 | 168 | 7 | 25c96df8ea0c7bbedbb7699ee84ad6234d19cba8 | |
| Drug | Sunitinib | 9.73e-10 | 8 | 163 | 5 | DB01268 | |
| Drug | ponatinib | 1.36e-09 | 68 | 163 | 9 | ctd:C545373 | |
| Drug | 5H-benzo(4,5)cyclohepta(1,2-b)pyridin-5-one | 7.25e-08 | 16 | 163 | 5 | ctd:C561052 | |
| Drug | verapamil | ABCA2 APOC3 ACE ABCA8 CHRNA7 CLCN3 KCNQ5 ABCB9 ABCA6 PKD1 KCNQ1 KCNQ2 PRKCD PRKCG ATP2A3 CHRFAM7A TAP2 | 9.24e-08 | 490 | 163 | 17 | CID000002520 |
| Drug | epicholesterol | VLDLR ABCA2 ZMPSTE24 CETP GPX7 APOC3 SCD5 ACE LYST ABCA8 CHRNA7 PNPLA6 ABCA6 PRF1 LRP5 SMPD2 ATP2A3 CHRFAM7A ABHD16A | 1.61e-07 | 636 | 163 | 19 | CID000000304 |
| Drug | glibenclamide | ABCA2 FLT4 ZMPSTE24 APOC3 ACE ABCA8 CLCN3 KCNQ5 ABCA6 GUCY2F KCNQ1 KCNQ2 PRKCD PRKCG | 6.96e-07 | 382 | 163 | 14 | CID000003488 |
| Drug | retigabine | 1.17e-06 | 48 | 163 | 6 | CID000121892 | |
| Drug | BMS-204352 | 1.72e-06 | 13 | 163 | 4 | CID000214350 | |
| Drug | Dichlorodiphenyldichloroethane | 1.83e-06 | 29 | 163 | 5 | ctd:D003632 | |
| Drug | Toluene | ACER2 FLT1 ABCA2 SAMD9 MAOA NTRK1 ETS1 SLC13A3 ACVRL1 ZZEF1 ACE CHRNA7 SLC6A8 SLC7A1 SMIM26 PRKCD HERC2 SLX4 GABRA2 | 1.87e-06 | 749 | 163 | 19 | ctd:D014050 |
| Drug | potassium | FLT4 GRIK1 GRIK5 ACE F5 CHRNA7 PLA2R1 SLC7A1 SLC7A3 CLCN3 KCNQ5 SLC14A1 GUCY2F RAPGEF3 PKD1 KCNQ1 KCNQ2 PRKCD PRKCG ATP2A3 CHRFAM7A GABRA2 | 3.23e-06 | 1008 | 163 | 22 | CID000000813 |
| Drug | tandutinib | 3.25e-06 | 15 | 163 | 4 | CID003038522 | |
| Drug | formylglycine | 3.57e-06 | 33 | 163 | 5 | CID000075606 | |
| Drug | carisbamate | 4.31e-06 | 16 | 163 | 4 | CID006918474 | |
| Drug | beta-tyrosine | 4.83e-06 | 35 | 163 | 5 | CID000440311 | |
| Drug | sunitinib malate | 6.53e-06 | 64 | 163 | 6 | CID006456015 | |
| Drug | N-(1-(3-morpholin-4-ylphenyl)ethyl)-3-phenylacrylamide | 7.09e-06 | 6 | 163 | 3 | ctd:C476437 | |
| Drug | Phosphamidon | 7.09e-06 | 6 | 163 | 3 | ctd:D010707 | |
| Drug | nitric oxide | IL12RB2 FLT1 MAOA MAOB PDGFRA GJB4 GPX7 GRIK1 ACE SLC7A1 SLC7A3 LCTL GUCY2F PRKCD PRKCG SMPD2 GJB7 LY75 IL1R1 ATP2A3 TAP2 AGTRAP | 8.96e-06 | 1075 | 163 | 22 | CID000145068 |
| Drug | NF T | 9.62e-06 | 190 | 163 | 9 | CID006436102 | |
| Drug | paramethoxyphenyl-acetyl dehydroalanine | 1.01e-05 | 69 | 163 | 6 | CID000130300 | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.23e-05 | 196 | 163 | 9 | 5386_DN | |
| Drug | Clofazimine [2030-63-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.29e-05 | 197 | 163 | 9 | 3239_DN | |
| Drug | POPC | MAOA MAOB CETP APOC3 ACVRL1 SCD5 PNPLA6 PRF1 PRKCD PRKCG SMPD2 | 1.35e-05 | 306 | 163 | 11 | CID000065167 |
| Drug | LY 300164 | 1.37e-05 | 43 | 163 | 5 | CID000126756 | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 1.39e-05 | 199 | 163 | 9 | 6228_UP | |
| Drug | LY 294002; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.39e-05 | 199 | 163 | 9 | 2676_DN | |
| Drug | imatinib | FLT1 FLT3 FLT4 PDGFRA MATK NTRK1 ACVRL1 JAK1 CSF1R CSK SMPD2 ALK EPHA3 | 1.41e-05 | 430 | 163 | 13 | CID000005291 |
| Drug | 3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; HL60; HT_HG-U133A | 1.45e-05 | 200 | 163 | 9 | 3044_UP | |
| Drug | PKC412 | 1.52e-05 | 74 | 163 | 6 | CID009829523 | |
| Drug | AC1L1JYL | ACER2 FLT1 FLT4 PDGFRA MATK NTRK1 GPR182 DEGS1 FAP PRKCD PRKCG SMPD2 CCR7 | 1.56e-05 | 434 | 163 | 13 | CID000005262 |
| Drug | oriens | 1.56e-05 | 154 | 163 | 8 | CID000161645 | |
| Drug | IN1076 | 1.63e-05 | 112 | 163 | 7 | CID000005309 | |
| Drug | sorafenib | 1.88e-05 | 158 | 163 | 8 | CID000216239 | |
| Drug | valrocemide | 1.96e-05 | 8 | 163 | 3 | CID006918293 | |
| Drug | 4-cyano-N-(2-(1-cyclohexen-1-yl)-4-(1-((dimethylamino)acetyl)-4-piperidinyl)phenyl)-1H-imidazole-2-carboxamide | 1.96e-05 | 8 | 163 | 3 | ctd:C549569 | |
| Drug | Imatinib | 1.96e-05 | 8 | 163 | 3 | DB00619 | |
| Drug | isovaleramide | 1.96e-05 | 8 | 163 | 3 | CID000010930 | |
| Drug | 4-quinolone | 1.96e-05 | 8 | 163 | 3 | CID000069141 | |
| Drug | eslicarbazepine acetate | 1.96e-05 | 8 | 163 | 3 | CID000179344 | |
| Drug | AC1L3VO5 | 2.05e-05 | 116 | 163 | 7 | CID000123015 | |
| Drug | Pc 12 | 2.22e-05 | 211 | 163 | 9 | CID003036508 | |
| Drug | BAPTA | CRLF1 GRIK1 CHRNA7 CISH FAP RAPGEF3 PRKCD PRKCG ATP2A3 CHRFAM7A GABRA2 | 2.30e-05 | 324 | 163 | 11 | CID000104751 |
| Drug | CCD 1042 | 2.85e-05 | 25 | 163 | 4 | CID000038022 | |
| Drug | lipo-polysaccharide | 2.93e-05 | 9 | 163 | 3 | CID011970143 | |
| Drug | lacosamide | 3.50e-05 | 52 | 163 | 5 | CID000219078 | |
| Drug | AC1OAGFB | PDGFRA MATK NTRK1 GRK4 KCNQ5 CSK RAPGEF3 DNM3 AGK KCNQ1 KCNQ2 CD72 PRKCD PRKCG | 3.52e-05 | 539 | 163 | 14 | CID006857345 |
| Drug | N-acetylhexosamine | MRC1 SUMF2 CETP NTRK1 ACE F5 FBXO2 FAP CSF1R C5 CLEC10A IL1R1 GP1BA | 3.72e-05 | 472 | 163 | 13 | CID000000899 |
| Drug | CI-1033 | 3.84e-05 | 53 | 163 | 5 | CID000156413 | |
| Drug | sunitinib | 4.28e-05 | 130 | 163 | 7 | CID005329102 | |
| Drug | hexanol | 5.03e-05 | 56 | 163 | 5 | CID000008103 | |
| Drug | I 1100 | 5.09e-05 | 2 | 163 | 2 | CID000013067 | |
| Drug | trimethyl citrate | 5.09e-05 | 2 | 163 | 2 | CID000074112 | |
| Drug | Pargyline | 5.09e-05 | 2 | 163 | 2 | DB01626 | |
| Drug | tribulin | 5.09e-05 | 2 | 163 | 2 | ctd:C039776 | |
| Drug | Isocarboxazid | 5.09e-05 | 2 | 163 | 2 | DB01247 | |
| Drug | NSC310407 | 5.09e-05 | 2 | 163 | 2 | CID000171344 | |
| Drug | C05636 | 5.09e-05 | 2 | 163 | 2 | CID000440736 | |
| Drug | 4,8-quinolinediol | 5.09e-05 | 2 | 163 | 2 | CID000440737 | |
| Drug | Tranylcypromine | 5.09e-05 | 2 | 163 | 2 | DB00752 | |
| Drug | ethyl 4-hydroxyphenylacetate | 5.09e-05 | 2 | 163 | 2 | CID000028310 | |
| Drug | AC1L2OJZ | 5.09e-05 | 2 | 163 | 2 | CID000125421 | |
| Drug | 5HAA | 5.09e-05 | 2 | 163 | 2 | CID000128291 | |
| Drug | methyl indole-3-propionate | 5.09e-05 | 2 | 163 | 2 | CID000021711 | |
| Drug | 3-methoxymethyl-7-(4,4,4-trifluorobutoxy)-3,3a,4,5-tetrahydro-1,3-oxazolo(3,4-a)quinolin-1-one | 5.09e-05 | 2 | 163 | 2 | ctd:C492672 | |
| Drug | 2-chloroquinoxaline | 5.09e-05 | 2 | 163 | 2 | CID000238938 | |
| Drug | Selegiline | 5.09e-05 | 2 | 163 | 2 | DB01037 | |
| Drug | 1 mm PP | 5.09e-05 | 2 | 163 | 2 | CID000132866 | |
| Drug | soman | 5.27e-05 | 92 | 163 | 6 | CID000007305 | |
| Drug | tetraethylammonium | 5.32e-05 | 236 | 163 | 9 | CID000005413 | |
| Drug | sunitinib | 5.48e-05 | 57 | 163 | 5 | ctd:C473478 | |
| Drug | nikkomycin | 5.70e-05 | 11 | 163 | 3 | CID000072479 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | PDGFRA MATK NTRK1 GPR182 GRIK1 ACE CISH RAPGEF3 PKD1 AGK CD72 PRKCD PRKCG ATP2A3 | 6.19e-05 | 568 | 163 | 14 | CID000000806 |
| Drug | 6-formylindolo(3,2-b)carbazole | 7.03e-05 | 60 | 163 | 5 | ctd:C111855 | |
| Drug | Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; HL60; HT_HG-U133A | 7.26e-05 | 191 | 163 | 8 | 2368_UP | |
| Drug | myo-inositol | PIGN PDGFRA MATK GPR182 GRIK1 PTH2R CHRNA7 CSK PKD1 DNM3 AGK CD72 PRKCD PRKCG ATP2A3 CHRFAM7A AGTRAP | 7.53e-05 | 811 | 163 | 17 | CID000000892 |
| Drug | Tiletamine hydrochloride; Down 200; 15.4uM; MCF7; HT_HG-U133A | 7.53e-05 | 192 | 163 | 8 | 6013_DN | |
| Drug | dGprG2'OMe | 7.56e-05 | 12 | 163 | 3 | CID000474412 | |
| Drug | pazopanib | 7.56e-05 | 12 | 163 | 3 | ctd:C516667 | |
| Drug | fumagillol | 7.56e-05 | 12 | 163 | 3 | CID000130042 | |
| Drug | Tipiracil | 7.61e-05 | 61 | 163 | 5 | CID006323266 | |
| Drug | N-methyl-DL-aspartic acid | DPYSL3 MAOB NTRK1 GRIK1 GRIK5 CHRNA7 FBXO2 GUCY2F PKD1 PRKCD PRKCG CHRFAM7A TAP2 EPHA3 GABRA2 | 7.70e-05 | 655 | 163 | 15 | CID000004376 |
| Drug | Cefalonium [5575-21-3]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 7.81e-05 | 193 | 163 | 8 | 7341_UP | |
| Drug | Glimepiride [93479-97-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 7.81e-05 | 193 | 163 | 8 | 4973_DN | |
| Drug | Zalcitabine [7481-89-2]; Up 200; 19uM; MCF7; HT_HG-U133A | 8.10e-05 | 194 | 163 | 8 | 7352_UP | |
| Drug | Dinoprost trometamol [38362-01-5]; Up 200; 8.4uM; PC3; HT_HG-U133A | 8.10e-05 | 194 | 163 | 8 | 6308_UP | |
| Drug | 5707885; Up 200; 50uM; PC3; HT_HG-U133A | 8.40e-05 | 195 | 163 | 8 | 6390_UP | |
| Drug | CP-690334-01 [459212-38-5]; Up 200; 10uM; PC3; HT_HG-U133A | 8.40e-05 | 195 | 163 | 8 | 4558_UP | |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; MCF7; HT_HG-U133A | 8.70e-05 | 196 | 163 | 8 | 4689_DN | |
| Drug | (d,l)-Tetrahydroberberine [522-97-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 8.70e-05 | 196 | 163 | 8 | 2818_UP | |
| Drug | XE991 | 8.81e-05 | 33 | 163 | 4 | CID000656732 | |
| Drug | Sulfachloropyridazine [80-32-0]; Up 200; 14uM; PC3; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 3769_UP | |
| Drug | Hymecromone [90-33-5]; Up 200; 22.8uM; HL60; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 3045_UP | |
| Drug | Kawain [500-64-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 4693_DN | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 9.01e-05 | 197 | 163 | 8 | 1003_UP | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 2326_DN | |
| Drug | Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; PC3; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 4604_UP | |
| Drug | halothane | GRIK1 ZZEF1 CHRNA7 PKD1 PRKCD PRKCG ATP2A3 CHRFAM7A CYP4F11 GABRA2 | 9.26e-05 | 314 | 163 | 10 | CID000003562 |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 9.34e-05 | 198 | 163 | 8 | 2316_DN | |
| Drug | Propidium iodide [25535-16-4]; Down 200; 6uM; MCF7; HT_HG-U133A | 9.34e-05 | 198 | 163 | 8 | 6104_DN | |
| Disease | non-arteritic anterior ischemic optic neuropathy (is_implicated_in) | 1.55e-06 | 5 | 160 | 3 | DOID:0050864 (is_implicated_in) | |
| Disease | Autistic Disorder | 1.76e-06 | 261 | 160 | 10 | C0004352 | |
| Disease | glucose-dependent insulinotropic peptide measurement | 1.02e-05 | 53 | 160 | 5 | EFO_0008464 | |
| Disease | long QT syndrome (implicated_via_orthology) | 1.83e-05 | 10 | 160 | 3 | DOID:2843 (implicated_via_orthology) | |
| Disease | Cholesteryl Ester Transfer Protein Deficiency | 2.92e-05 | 2 | 160 | 2 | C0342883 | |
| Disease | hypereosinophilic syndrome (is_implicated_in) | 2.92e-05 | 2 | 160 | 2 | DOID:999 (is_implicated_in) | |
| Disease | Sudden infant death syndrome | 3.32e-05 | 12 | 160 | 3 | C0038644 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 4.30e-05 | 13 | 160 | 3 | DOID:0112202 (implicated_via_orthology) | |
| Disease | Alpha ketoglutarate measurement | 8.32e-05 | 16 | 160 | 3 | EFO_0010457 | |
| Disease | hydroquinone sulfate measurement | 8.73e-05 | 3 | 160 | 2 | EFO_0021157 | |
| Disease | secretory phospholipase A2 receptor measurement | 8.73e-05 | 3 | 160 | 2 | EFO_0802043 | |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 1.02e-04 | 85 | 160 | 5 | DOID:9744 (is_implicated_in) | |
| Disease | neuritic plaque measurement | SLC13A3 GRIK5 SYNPR SVEP1 CHRNA7 TRIM69 CDYL2 CHRFAM7A CYP4F11 | 1.29e-04 | 349 | 160 | 9 | EFO_0006798 |
| Disease | sphingomyelin measurement | 1.46e-04 | 278 | 160 | 8 | EFO_0010118 | |
| Disease | Hypereosinophilic syndrome | 1.74e-04 | 4 | 160 | 2 | C1540912 | |
| Disease | autosomal dominant polycystic kidney disease (is_implicated_in) | 1.74e-04 | 4 | 160 | 2 | DOID:898 (is_implicated_in) | |
| Disease | erythrokeratodermia variabilis (is_implicated_in) | 1.74e-04 | 4 | 160 | 2 | DOID:0050467 (is_implicated_in) | |
| Disease | Metastatic melanoma | 2.13e-04 | 54 | 160 | 4 | C0278883 | |
| Disease | Hyperlipoproteinemias | 2.89e-04 | 5 | 160 | 2 | C0020476 | |
| Disease | Bipolar Disorder | MAOA MAOB NTRK1 GRIK1 GRIK5 ACE CHRNA7 KCNQ2 CLEC10A CHRFAM7A | 2.92e-04 | 477 | 160 | 10 | C0005586 |
| Disease | pre-eclampsia (is_implicated_in) | 3.30e-04 | 25 | 160 | 3 | DOID:10591 (is_implicated_in) | |
| Disease | Schizophrenia | VLDLR MAOA MAOB NTRK1 GRIK1 GRIK5 ACE CHRNA7 TMEM245 KCNQ2 CHRFAM7A TAP2 ALK NPAS4 | 3.40e-04 | 883 | 160 | 14 | C0036341 |
| Disease | carcinoma (implicated_via_orthology) | 4.11e-04 | 64 | 160 | 4 | DOID:305 (implicated_via_orthology) | |
| Disease | cognitive disorder (implicated_via_orthology) | 4.32e-04 | 6 | 160 | 2 | DOID:1561 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis (biomarker_via_orthology) | 4.32e-04 | 6 | 160 | 2 | DOID:7148 (biomarker_via_orthology) | |
| Disease | portal hypertension (is_marker_for) | 4.32e-04 | 6 | 160 | 2 | DOID:10762 (is_marker_for) | |
| Disease | Dermatitis, Allergic Contact | 4.89e-04 | 67 | 160 | 4 | C0162820 | |
| Disease | Non-alcoholic Fatty Liver Disease | 5.78e-04 | 70 | 160 | 4 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 5.78e-04 | 70 | 160 | 4 | C3241937 | |
| Disease | polycystic liver disease (implicated_via_orthology) | 6.03e-04 | 7 | 160 | 2 | DOID:0050770 (implicated_via_orthology) | |
| Disease | serum metabolite measurement | CA12 ACADM CETP SLC13A3 TM2D3 GRIK5 ACE TMEM229B SACM1L CSF1R SLC22A16 SORCS3 PRKCD ALK | 6.63e-04 | 945 | 160 | 14 | EFO_0005653 |
| Disease | Squamous cell carcinoma of lung | 6.91e-04 | 32 | 160 | 3 | C0149782 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 7.13e-04 | 74 | 160 | 4 | DOID:3748 (is_marker_for) | |
| Disease | stem Cell Growth Factor beta measurement | 7.50e-04 | 75 | 160 | 4 | EFO_0008292 | |
| Disease | psoriasis | 7.53e-04 | 273 | 160 | 7 | EFO_0000676 | |
| Disease | Alzheimer's disease (is_implicated_in) | 7.83e-04 | 132 | 160 | 5 | DOID:10652 (is_implicated_in) | |
| Disease | Leydig cell tumor (is_marker_for) | 8.01e-04 | 8 | 160 | 2 | DOID:2696 (is_marker_for) | |
| Disease | 1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4) measurement | 8.01e-04 | 8 | 160 | 2 | EFO_0800423 | |
| Disease | 1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1) measurement | 8.01e-04 | 8 | 160 | 2 | EFO_0800420 | |
| Disease | Cardiovascular Diseases | 9.80e-04 | 36 | 160 | 3 | C0007222 | |
| Disease | liver cirrhosis (is_marker_for) | 1.05e-03 | 82 | 160 | 4 | DOID:5082 (is_marker_for) | |
| Disease | Calcium channel blocker use measurement | 1.11e-03 | 213 | 160 | 6 | EFO_0009930 | |
| Disease | type 1 diabetes mellitus (implicated_via_orthology) | 1.24e-03 | 39 | 160 | 3 | DOID:9744 (implicated_via_orthology) | |
| Disease | Seizures | 1.25e-03 | 218 | 160 | 6 | C0036572 | |
| Disease | hydroxyproline measurement | 1.28e-03 | 10 | 160 | 2 | EFO_0010498 | |
| Disease | 1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) measurement | 1.28e-03 | 10 | 160 | 2 | EFO_0800464 | |
| Disease | Inherited neuropathies | 1.33e-03 | 40 | 160 | 3 | C0598589 | |
| Disease | serum albumin measurement | 1.52e-03 | 592 | 160 | 10 | EFO_0004535 | |
| Disease | hypertension (biomarker_via_orthology) | 1.54e-03 | 227 | 160 | 6 | DOID:10763 (biomarker_via_orthology) | |
| Disease | central corneal thickness | 1.54e-03 | 309 | 160 | 7 | EFO_0005213 | |
| Disease | T-cell acute lymphoblastic leukemia (is_implicated_in) | 1.56e-03 | 11 | 160 | 2 | DOID:5603 (is_implicated_in) | |
| Disease | placenta growth factor measurement | 1.56e-03 | 11 | 160 | 2 | EFO_0010626 | |
| Disease | liver cirrhosis (is_implicated_in) | 1.65e-03 | 43 | 160 | 3 | DOID:5082 (is_implicated_in) | |
| Disease | eosinophil percentage of granulocytes | 1.79e-03 | 234 | 160 | 6 | EFO_0007996 | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.86e-03 | 12 | 160 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | Huntington Disease, Late Onset | 1.86e-03 | 12 | 160 | 2 | C0393574 | |
| Disease | 1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) measurement | 1.86e-03 | 12 | 160 | 2 | EFO_0800466 | |
| Disease | Intestinal Neoplasms | 1.86e-03 | 12 | 160 | 2 | C0021841 | |
| Disease | Akinetic-Rigid Variant of Huntington Disease | 1.86e-03 | 12 | 160 | 2 | C0751207 | |
| Disease | Juvenile Huntington Disease | 1.86e-03 | 12 | 160 | 2 | C0751208 | |
| Disease | Intestinal Cancer | 1.86e-03 | 12 | 160 | 2 | C0346627 | |
| Disease | thyroid gland carcinoma (is_marker_for) | 1.86e-03 | 12 | 160 | 2 | DOID:3963 (is_marker_for) | |
| Disease | Thrombus | 2.00e-03 | 46 | 160 | 3 | C0087086 | |
| Disease | basophil count, eosinophil count | 2.08e-03 | 241 | 160 | 6 | EFO_0004842, EFO_0005090 | |
| Disease | Celiac Disease | 2.13e-03 | 47 | 160 | 3 | C0007570 | |
| Disease | ximenoylcarnitine (C26:1) measurement | 2.19e-03 | 13 | 160 | 2 | EFO_0800543 | |
| Disease | Fulminant Hepatic Failure with Cerebral Edema | 2.19e-03 | 13 | 160 | 2 | C0751197 | |
| Disease | Hepatic Stupor | 2.19e-03 | 13 | 160 | 2 | C0751198 | |
| Disease | Hepatic Encephalopathy | 2.19e-03 | 13 | 160 | 2 | C0019151 | |
| Disease | Hepatic Coma | 2.19e-03 | 13 | 160 | 2 | C0019147 | |
| Disease | leukemia (is_implicated_in) | 2.19e-03 | 13 | 160 | 2 | DOID:1240 (is_implicated_in) | |
| Disease | Hyperlipoproteinemia Type IIb | 2.19e-03 | 13 | 160 | 2 | C1704417 | |
| Disease | Depressed mood | 2.19e-03 | 13 | 160 | 2 | C0344315 | |
| Disease | Generalized seizures | 2.26e-03 | 101 | 160 | 4 | C0234533 | |
| Disease | Clonic Seizures | 2.26e-03 | 101 | 160 | 4 | C0234535 | |
| Disease | Convulsive Seizures | 2.26e-03 | 101 | 160 | 4 | C0751494 | |
| Disease | Seizures, Sensory | 2.26e-03 | 101 | 160 | 4 | C0751496 | |
| Disease | Non-epileptic convulsion | 2.26e-03 | 101 | 160 | 4 | C0751056 | |
| Disease | Atonic Absence Seizures | 2.26e-03 | 101 | 160 | 4 | C0751123 | |
| Disease | Complex partial seizures | 2.26e-03 | 101 | 160 | 4 | C0149958 | |
| Disease | Single Seizure | 2.26e-03 | 101 | 160 | 4 | C0751110 | |
| Disease | Nonepileptic Seizures | 2.26e-03 | 101 | 160 | 4 | C3495874 | |
| Disease | Visual seizure | 2.26e-03 | 101 | 160 | 4 | C0270824 | |
| Disease | Epileptic drop attack | 2.26e-03 | 101 | 160 | 4 | C0270846 | |
| Disease | Vertiginous seizure | 2.26e-03 | 101 | 160 | 4 | C0422855 | |
| Disease | Gustatory seizure | 2.26e-03 | 101 | 160 | 4 | C0422854 | |
| Disease | Seizures, Somatosensory | 2.26e-03 | 101 | 160 | 4 | C0422850 | |
| Disease | Olfactory seizure | 2.26e-03 | 101 | 160 | 4 | C0422853 | |
| Disease | Seizures, Auditory | 2.26e-03 | 101 | 160 | 4 | C0422852 | |
| Disease | Generalized Absence Seizures | 2.26e-03 | 101 | 160 | 4 | C4505436 | |
| Disease | Jacksonian Seizure | 2.26e-03 | 101 | 160 | 4 | C0022333 | |
| Disease | Epileptic Seizures | 2.26e-03 | 101 | 160 | 4 | C4317109 | |
| Disease | Absence Seizures | 2.34e-03 | 102 | 160 | 4 | C4316903 | |
| Disease | Convulsions | 2.34e-03 | 102 | 160 | 4 | C4048158 | |
| Disease | Tonic Seizures | 2.34e-03 | 102 | 160 | 4 | C0270844 | |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 2.39e-03 | 170 | 160 | 5 | EFO_0000685, EFO_0007791, EFO_0007837 | |
| Disease | cholestasis (biomarker_via_orthology) | 2.40e-03 | 49 | 160 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 2.40e-03 | 49 | 160 | 3 | EFO_0021897 | |
| Disease | Thrombosis | 2.40e-03 | 49 | 160 | 3 | C0040053 | |
| Disease | Seizures, Focal | 2.51e-03 | 104 | 160 | 4 | C0751495 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FLWLVGSSAWAKGLS | 126 | Q8TBG9 | |
| ASEPSWWTTGKYGIF | 421 | Q9H993 | |
| WGSFRDAGVKVSKYW | 211 | Q53H12 | |
| KGTLKYGYTTAWWLG | 111 | P11597 | |
| KLGLFSGLWWTLALF | 176 | Q5QJU3 | |
| KQDGFTDTGAYWRSW | 216 | P12821 | |
| YEWSVKLNWTGTSKS | 81 | O95433 | |
| SLLSFGYLSWDWAKP | 11 | Q5FYB1 | |
| GYLSWDWAKPSFVAD | 16 | Q5FYB1 | |
| ASLGIDGTHYWSKNW | 281 | Q14195 | |
| GLWTRDTSWALLYFL | 11 | P39086 | |
| SAFWLSWGLIYAGFI | 261 | Q8N139 | |
| IYAWSIGGFTATWAA | 351 | O95870 | |
| LPFWAYSAAKSWVFG | 111 | P32248 | |
| DVTTAWGGDYWRLLT | 651 | Q96SM3 | |
| ESYKWTDIWAFGLVL | 391 | P37023 | |
| TDTGWVKAAWTLFSA | 271 | Q6NUN0 | |
| KSDVWSFGILLWEIY | 366 | P41240 | |
| SWGKVWYLNEASFDL | 126 | A8MUL3 | |
| AKTFSYLRESGWYWG | 71 | Q9NSE2 | |
| SLGFSYSWWKNSVGS | 46 | Q6NUI1 | |
| SYWTGLSSNKDWKLT | 296 | P21854 | |
| LSGTWLSGLLAAFWY | 181 | Q6ZPD9 | |
| WITNGGKANWYFLLA | 191 | P11310 | |
| YRVTGYGGWSWISKT | 1026 | Q12830 | |
| FSGRLGGYWKTWIFW | 171 | P51861 | |
| FRKTYIGWKTWIFSG | 196 | P51861 | |
| YSTSSLALGLAWLSW | 126 | Q13536 | |
| WLQKWYGGASSISRE | 266 | Q8IUH2 | |
| GVYVGLATVAAATWW | 841 | Q93084 | |
| LKFGSWSYGGWSLDL | 166 | P36544 | |
| LVVYGWSVGGFTATW | 241 | Q9H3Z7 | |
| ALAVGSAFYTIWSGW | 41 | Q9NXS2 | |
| KWSFGTTLWEICYNG | 776 | P23458 | |
| ATILFWAAAAWAKSG | 6 | Q2M385 | |
| ALWFLWYVKQCGGTT | 191 | P21397 | |
| SALWFLWYVKQCGGT | 181 | P27338 | |
| SDVWSYGILLWEIFS | 876 | P16234 | |
| DLSTYGDSLSGWWLL | 1166 | Q8IY17 | |
| WSFGVVLWEIFTYGK | 711 | P04629 | |
| FGSYADALWWGVVTV | 296 | P51787 | |
| FTSKSDVWSFGVLLW | 401 | P42679 | |
| CKGSGYSFTSYWISW | 41 | A0A0J9YXX1 | |
| QGLKYTFSVDWWSFG | 521 | Q05655 | |
| TKSGVVWTWGKGDYF | 3221 | O95714 | |
| LSGYYWQTSAKWLRS | 16 | Q8IZA0 | |
| AKVGDWFRSWGYVLL | 481 | Q9H9K5 | |
| STYADALWWGTITLT | 296 | Q9NR82 | |
| FALTLSGDTLYWTDW | 241 | O75197 | |
| YKGSWSDWSESLRAQ | 301 | Q99665 | |
| SWKGIYFILTLFWGS | 41 | Q6UWP7 | |
| YFTKRGWAWDGKSVV | 336 | P47869 | |
| KWTYFGPDGENSWSK | 31 | O43570 | |
| GYWFVLTAESLSWYK | 546 | Q9UQ16 | |
| QSFISWTGDGWEFKL | 351 | P14921 | |
| SVYWKGWFGARVTNS | 276 | Q9UK22 | |
| WALDGLSFTYSLVIW | 156 | P17181 | |
| FWKLWISYVNGSLFS | 466 | Q96KP1 | |
| FDTYADALWWGLITL | 261 | O43526 | |
| DALWWGLITLTTIGY | 266 | O43526 | |
| GYTSWSLLDKFEWEK | 451 | Q6UWM7 | |
| YSKPWISSFWGLFLQ | 191 | Q8NGJ9 | |
| WKYQSGLSSSWLSLE | 166 | Q5SWX8 | |
| GLWGDWFTATDAYVK | 426 | P14222 | |
| WAYGFGWAATIILIG | 151 | Q96FX8 | |
| FISWTGDGWEFKLAD | 381 | P15036 | |
| KSWYPFWGAASFLIS | 91 | Q96PG2 | |
| FEWSDGSTFDYIPWK | 1466 | O60449 | |
| PYGKSVDWWSFGVLL | 531 | P05129 | |
| ATAYSKSVWDLGWFV | 96 | Q8TDV0 | |
| LKFGSWSYGGWSLDL | 76 | Q494W8 | |
| IIKFWDEFGYLSANW | 461 | Q9Y6X9 | |
| AYSSWKFSGGFRTWV | 226 | Q9H813 | |
| RWWATFASYVIGLGL | 321 | O60906 | |
| AKTGGWAWIYCLLYS | 286 | Q8IUM7 | |
| VWSYGILLWEIFSLG | 871 | P36888 | |
| IWSGKTLNSWRKFYT | 621 | Q9UP38 | |
| SDVWSYGILLWEIFS | 836 | P07333 | |
| DWLLNEGKCYWFSTS | 81 | D3W0D1 | |
| PDSLVYGADWSWLLF | 331 | Q9BTV6 | |
| QWLLGEWACKLYTGF | 106 | Q8NGA4 | |
| YSVWKGGSASTWLTA | 1066 | P01031 | |
| GGSWLLARVLAWTYT | 26 | Q9HBI6 | |
| SLLGNSWDKGIFSWA | 136 | P51841 | |
| LYDNLSKKRGGLWWT | 116 | Q9NTQ9 | |
| TAGWYLWSATGLGFL | 186 | Q9Y2G2 | |
| LLSSAFAFGWSKWNL | 601 | Q6TDU7 | |
| WKWVIFGAYAFGSCI | 66 | O15121 | |
| LQKSYWLGSGRTEAW | 931 | Q9BZC7 | |
| FTSASDVWSYGIVLW | 801 | P29320 | |
| LSWIKGLKWGEYVGS | 3461 | Q99698 | |
| TKAHTTPWGLFYSWS | 316 | P07359 | |
| SGVNKYSTGTGWIWL | 11 | Q6PEY0 | |
| PSYFIKRESWGWTDF | 146 | Q9NPA0 | |
| NWISGLAFPDWAYKA | 16 | Q6ZN32 | |
| SGVWWAFTLIIISSY | 621 | Q16478 | |
| EKYTFSPDWWGLGCL | 361 | P32298 | |
| YLAQTSGKEPTWNFW | 131 | Q96SL4 | |
| GAVLLFSWTVYLWET | 21 | O75844 | |
| FGIYGSKKAGIWSEW | 316 | O75462 | |
| LAGWLWISFLYGGLS | 291 | Q8WWT9 | |
| WTETLAYVLFWGVAS | 546 | Q9NTJ5 | |
| TGQLSDIAYWKWNGS | 251 | P14778 | |
| LWFTASVTGAAWYLA | 181 | O14569 | |
| SYVTVGELWAFTTGW | 101 | Q8WY07 | |
| FSKGSDVWSYGVLLW | 326 | P80192 | |
| SAFLKAWVYWPGEDT | 336 | O75807 | |
| SGVVYTWSLEEGLSW | 1746 | P98161 | |
| LDAWYDLTSSGESWK | 536 | Q86XP0 | |
| KGSGLWSRWKIYGTT | 131 | P22897 | |
| LFKFLSSWSLWGANY | 261 | Q16518 | |
| GLYDLLGNVWEWTAS | 226 | Q8NBJ7 | |
| FIYVWELSWGLGLRT | 316 | B2RXF0 | |
| TLWTYLWEFTTGFIL | 81 | Q8NBD8 | |
| QITASSFKKSWWGDY | 2081 | P12259 | |
| FSKGSDIWSYGVLLW | 321 | Q5TCX8 | |
| QLGTLTYFWWFGNST | 941 | Q9UPU3 | |
| TYFWWFGNSTKPLIT | 946 | Q9UPU3 | |
| TVWLIWFTGSLGFYS | 361 | Q86VW1 | |
| GGKVSWWNFYFSSES | 686 | Q5K651 | |
| SGSRDATLLLWYWSG | 2741 | Q8NFP9 | |
| LEVTLDYTWLWGSFS | 111 | O15218 | |
| ASWGADRSYWKEFLV | 706 | Q9NPR2 | |
| NTEKILNYWKSWTGG | 76 | A0A096LP01 | |
| GAVGSLLLEWYGWQS | 171 | Q9BYT1 | |
| WLLVGYGAAGLSWSL | 101 | Q03519 | |
| YGAAGLSWSLWAVLS | 106 | Q03519 | |
| IWGESLWNSYFLASI | 211 | Q86SK9 | |
| ILDIWFDSGTSWSYV | 596 | Q9NSE4 | |
| YSASGTTLLWQAFWE | 476 | P48029 | |
| KGAGYSFAVDWWSLG | 196 | Q8WU08 | |
| GSWSQKRSFVYVWKT | 141 | P40967 | |
| TWTSANGIWKVYIDG | 1516 | Q4LDE5 | |
| LSKYGASWWIGLQEE | 866 | Q13018 | |
| KQSFLWEGSALTGAW | 526 | Q8IY92 | |
| RDSAFWLSWGLLYAG | 261 | O94911 | |
| FWALFVWTYISLGAS | 116 | Q9NP78 | |
| FTSKTDTWSFGVLLW | 1306 | Q9UM73 | |
| GWVTDGFSSLKDYWS | 61 | P02656 | |
| LIRWKGYGSTEDTWE | 26 | Q8N8U2 | |
| GAWKWVDGTDYATGF | 246 | Q8IUN9 | |
| GGTWNDLSCYKTTYW | 356 | Q6ZS10 | |
| SLYDAWSGWLVVTLT | 121 | P51790 | |
| SPWVKEDGSIAWGSY | 216 | Q8IXP5 | |
| WLLTTWGCIVFSGSY | 16 | Q6RW13 | |
| ALWWSPNGKFLAYAE | 211 | Q12884 | |
| WGWSYGGYVSSLALA | 621 | Q12884 | |
| AVLGSRGFTSGKWYW | 366 | Q86WT6 | |
| RGFTSGKWYWEVEVA | 371 | Q86WT6 | |
| QGDKGTSWYIIWKGS | 276 | O95398 | |
| FSYKPWFTGWSVRIA | 31 | A6NML5 | |
| FGWTWISLVGSSDDY | 206 | Q7RTX1 | |
| SYVTVGELWAFITGW | 101 | P30825 | |
| LIFWGSSLLGARLYW | 231 | Q8N394 | |
| YTTQSDVWSFGVLLW | 1091 | P35916 | |
| NIFWTGGEDTILYSW | 301 | A0A1W2PR48 | |
| WGTYFKAVDLSWSAL | 56 | Q6P2S7 | |
| DWWSFGSLLYELLTG | 466 | Q9Y6S9 | |
| IDSYTWGISWFGFAI | 226 | O00322 | |
| FSDKGDYFWWLLLPV | 136 | Q13336 | |
| LFNESKYTWSWGSPD | 126 | O95427 | |
| SDTKYLWGFILIGWG | 271 | P49190 | |
| FWAWLALGFSLAVYG | 51 | Q9BTX3 | |
| LDYFSSLWIWTLVVG | 186 | Q9H330 | |
| KSGVSVSDASAIWYW | 386 | O43149 | |
| GFDAFWPSLEYKIWL | 981 | Q5TAH2 | |
| DSFWYSILGGLWDFD | 136 | Q8N859 | |
| WLSFDEGRSWSKYSF | 611 | Q8WY21 | |
| YSTKSDVWSYGVLLW | 1076 | P17948 | |
| DVWSYGVLLWEIFSL | 1081 | P17948 | |
| ASWGSGTKDLAPWAY | 231 | Q9H091 | |
| LYCNWTGGYKWSTAL | 176 | Q9BRN9 | |
| DLKDTWYLIGIVSWG | 376 | Q6ZMR5 | |
| VDYGTSAGVWSQDKW | 456 | Q9BYJ9 | |
| KWYVFLISFWGEQIG | 221 | Q9Y487 | |
| LSGFVYWSDWGEPAK | 566 | P98155 | |
| LYKSDLEWLRGIGWS | 2411 | P20929 |